mitomycin has been researched along with epirubicin in 246 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (5.28) | 18.7374 |
| 1990's | 108 (43.90) | 18.2507 |
| 2000's | 74 (30.08) | 29.6817 |
| 2010's | 44 (17.89) | 24.3611 |
| 2020's | 7 (2.85) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Benfenati, E; Raska, I; Toropov, AA; Toropova, AP | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Mauceri, G; Mazzone, G; Morgia, G; Motta, M | 1 |
| Eto, T; Ishinoda, Y; Iwaki, Y; Kawano, T; Kitamura, M; Kitamura, T; Komura, K; Maruyama, T; Shimada, Y; Tamaki, N | 1 |
| Airoma, G; Bianco, AR; Gridelli, C; Incoronato, P; Palazzolo, G; Pepe, R; Rossi, A | 1 |
| Thongprasert, S | 1 |
| Handagoon, P; Nakamura, H; Phornphutkul, K; Senarat, S; Sirivanichai, C | 1 |
| Hashimoto, M; Iwamiya, T; Kawasaki, H; Kobayashi, M; Morioka, N; Nakamura, K; Ohta, Y; Okuda, Y; Sawada, S; Tanigawa, N | 1 |
| Cimoli, G; Conte, P; Conzi, G; Noviello, E; Orengo, G; Pagnan, G; Parodi, S; Russo, P; Schenone, F; Venturini, M | 1 |
| Chang, YC; Kohno, H; Nagasue, N; Nakamura, T; Ohiwa, K; Yamanoi, A | 1 |
| Balansky, RM; Blagoeva, PM; Mircheva, TJ; Simeonova, MI | 1 |
| Balli, M; Bonciarelli, G; Jirillo, A; Lonardi, F; Pavanato, G | 1 |
| Fujii, S | 1 |
| Bonichon, F; Chauvergne, J; Dilhuydy, JM; Durand, M; Mauriac, L | 1 |
| Narasimha, K | 1 |
| Fukawa, M; Hiroyoshi, M; Imaizumi, N; Matsumoto, S; Okushima, K; Tabuchi, M; Takeda, T; Yakushiji, H | 1 |
| Adachi, W; Haba, Y; Hanasaki, K; Horigome, N; Kajikawa, S; Kaneko, G; Kobayashi, M; Koide, N; Koike, S; Shiohara, E | 1 |
| Awane, Y; Maeshiro, T; Matsumine, T; Miyamoto, S; Umekita, N; Yamada, F | 1 |
| Hayashi, T; Kimoto, T; Kohno, H; Makino, Y; Nagasue, N; Ohiwa, K; Ono, T; Takemoto, Y; Taniura, H; Uchida, M | 1 |
| Weissbach, L | 1 |
| Brandão, T; da Silva, FC; Ferrito, F; Santos, A | 1 |
| Cold, S; Pfeiffer, P; Rose, C | 1 |
| Crawford, ED; Thrasher, JB | 1 |
| Edler, L; Flechtner, H; Fritz, M; Heim, ME; Queisser, W; Trux, F; Verhees, S | 1 |
| Yamada, S | 1 |
| Kido, Y; Kobayashi, K; Matsuura, N; Mori, T; Murata, A; Nishijima, J; Ogawa, M; Shiozaki, H; Tsujinaka, T | 1 |
| Coombes, RC; Glees, J; Rawson, NS; Topham, C; Woods, EM | 1 |
| Newling, DW | 1 |
| Avril, A; Dilhuydy, JM; Durand, M; Mauriac, L | 1 |
| Kolarić, K; Luetić, J; Roth, A; Zupanc, D | 1 |
| Chisholm, GD; Hargreave, TB; James, K; Prescott, S; Smyth, JF | 1 |
| Balli, M; Bonciarelli, G; Demicheli, R; Jirillo, A; Lonardi, F | 1 |
| Buxton, J; Chetiyawardana, A; Crawford, M; Lawton, F; Mould, J; O'Brien, M; Patterson, M; Redman, C; Stuart, N; Sykes, V | 1 |
| Furukohori, N; Itoh, T; Munakata, A; Saitoh, S; Sakata, Y; Suzuki, H; Takagi, S; Tamura, Y; Tsushima, K; Yoshida, Y | 1 |
| Edler, L; Flechtner, H; Heim, ME; Kabelitz, K; Massner, B; Queisser, W | 1 |
| Casanova, L; Celis, J; Montalbetti, J; Nuñez, J; Otero, J; Payet, C; Salazar, F; Sánchez, J; Solidoro, A; Vallejos, C | 1 |
| Chauvergne, J; David, M; Durand, M; Hoerni, B; Mauriac, L | 1 |
| Aeikens, B; de Riese, W; Lenis, G; Schindler, E | 1 |
| Groos, E; Masters, JR | 1 |
| Groos, E; Masters, JR; Walker, L | 1 |
| Arnold, H; Flechtner, H; Fritsch, H; Fritz, M; Fritze, D; Heim, ME; Henss, H; Herrmann, R; Queisser, W; Trux, FA | 1 |
| Burk, K; de Riese, W; Schultze-Seemann, W; Sropp, C | 1 |
| Higuchi, T; Kikuchi, M; Okazaki, M | 1 |
| Algeri, R; Guarnieri, A; Neri, B; Pacini, P; Rinaldini, M; Tucci, E; Valzelli, S | 1 |
| Abad, A; Ariza, A; Barnadas, A; Carles, J; Fernandez-Vasalo, G; Pellicer, I; Rosell, R; Sanchez, JJ | 1 |
| Bajardi, G; Cannata, G; Cipolla, C; Curto, G; Gebbia, V; Latteri, M; Mastrandrea, G; Pischedda, G; Testa, A; Valenza, R | 1 |
| Kudo, C; Saito, M; Yoshida, T | 1 |
| Kosmidis, P; Kyparidou, E; Lygidakis, NJ; Parissis, J; Ziras, N | 1 |
| Akiyama, J; Hyogo, H; Ito, K; Kida, M; Kido, S; Kojima, K; Matsuda, M; Matsuura, M; Nakajima, N; Yamamoto, K | 1 |
| Fukuma, E; Goto, S; Imai, I; Ishiyama, J; Kano, N; Kasugai, H; Kera, J; Miyajima, N; Takeuchi, S; Yamakawa, T | 1 |
| Hiraoka, M; Itani, K; Kondo, M; Miura, K; Noguchi, M; Tanaka, Y; Watanabe, N; Yoshikawa, T | 1 |
| Gu, Q; Ji, T; Sun, J | 1 |
| Shi, ZH; Wang, ZY; Zai, RY | 1 |
| Kanematsu, M | 1 |
| Miura, T; Shinohara, K | 1 |
| Imai, M; Katsuki, Y; Nishimura, A; Tsuji, Y; Yasuda, T | 1 |
| Inagaki, Y; Miyakawa, A; Nakamura, J; Nakasato, Y; Ogawa, R; Okamoto, T; Onda, K; Ono, M; Shiino, Y; Yokota, T | 1 |
| Aso, T; Gao, Y; Ozaki, Y; Shimizu, M; Yamada, S | 1 |
| Fujiwara, Y; Hata, Y; Higaki, T; Hisa, N; Kamiike, O; Morita, S; Yoshida, D; Yoshida, S | 1 |
| Morita, S; Motohara, T; Ozawa, Z | 1 |
| Algeri, R; Bella, M; Cocconi, G; De Lisi, V; Di Costanzo, F; Luppi, G; Mazzocchi, B; Rodinò, C; Soldani, M; Zironi, S | 1 |
| Asaishi, K; Hirata, K; Masuoka, H; Narimatsu, E; Okazaki, A; Okazaki, M; Toda, K | 1 |
| Akashi, H; Inoue, Y; Mizumoto, S; Nakamura, H; Yamasaki, K; Yano, M | 1 |
| Iwamiya, T; Ohta, Y; Sawada, S | 1 |
| Dyrda, Z; Rzymowska, J | 1 |
| Kurita, A; Matsuzaka, T; Sakakihara, Y; Takashima, S; Tsunekawa, K | 1 |
| Hasegawa, S; Iizuka, I; Kojima, Y; Nomura, Y; Suzuki, H; Tada, K | 1 |
| Kunii, Y; Mashiko, H; Momono, S; Muto, I; Nakagawa, K; Ouchi, A; Shiiba, K; Wada, M; Yamamoto, K; Yamazaki, T | 2 |
| Ishikawa, A; Ito, K; Matsuda, M; Matsuura, M; Nakajima, N; Ozawa, M; Suzuki, K; Toyama, K | 1 |
| Abo, H; Kantoh, T; Tomotsu, K; Usui, T | 1 |
| Akimoto, K; Fujita, M; Katsumori, T; Kohda, Y; Maeda, T; Nakano, Y; Ohno, K; Satoh, O; Takahashi, T | 1 |
| Kono, H; Minami, K; Nagata, N; Sato, Y; Yamamoto, T | 1 |
| Coombes, RC; Glees, J; Topham, C | 1 |
| Hasegawa, S; Koga, H; Kotoh, S; Kumazawa, J; Kuwano, M; Naito, S; Yokomizo, A | 1 |
| Bono, AV; Denis, L; Hall, RR; Lovisolo, JA; Sylvester, R | 1 |
| Akima, K; Atomi, Y; Hagi, H; Ito, H; Iwata, Y; Matsuo, K; Oshima, K; Tatekawa, I; Watari, N; Yagita, A; Yanagi, M | 1 |
| Klonaris, C; Kosmas, C; Kosmidis, P; Lisaios, B; Mandrekois, D; Mylonakis, N; Sakelaropoulos, N; Soumilas, A; Tentas, K; Tsavaris, NB; Tsetis, A | 1 |
| Geromichalos, GD; Hadjikostas, CC; Katsoulos, GA; Kortsaris, AH; Kyriakidis, DA | 1 |
| Hayashi, N; Ikeba, K; Kinoshita, K; Ohokubo, T; Sodemoto, T; Takagi, A; Takeda, S; Yamamoto, T | 1 |
| Bonichon, F; Coindre, JM; de Mascarel, I; Durand, M; MacGrogan, G; Mauriac, L; Trojani, M | 1 |
| Hayashi, N; Ishii, Y; Kimoto, T; Kitagawa, M; Muramatsu, I; Sakai, T | 1 |
| Fujita, Y; Inoue, K; Inoue, Y; Kasahara, K; Morioka, M; Shuin, T; Yamashita, M | 1 |
| Yamazaki, N | 1 |
| Belli, L; Colombo, E; Cornalba, GP; Damiani, G; Magistretti, G; Puricelli, GP | 1 |
| Harada, A; Kurokawa, T; Nakao, A; Nonami, T; Takagi, H; Takeuchi, Y; Taniguch, K; Yasui, M | 1 |
| Kokawa, Y; Oura, S; Sakurai, T; Tamaki, T; Umemura, T; Yoshimura, G | 1 |
| Aitini, E; Amadori, M; Bertani, M; Bezzi, A; Campo, S; Cantore, M; Cavazzini, G; Mambrini, A; Pari, F; Pulica, C; Rabbi, C; Smerieri, F; Zamagni, D | 1 |
| Aikawa, K; Ishibashi, K; Koseki, K; Ogihara, M; Shiraiwa, Y; Yamaguchi, O | 1 |
| Chang, HT; Mok, KT; Tzeng, WS | 1 |
| Ikeuchi, T; Kogawa, T; Kokawa, A; Maeda, S; Tanaka, K; Yamamoto, K; Yamamura, H; Yoshii, T | 1 |
| Baba, S; Ishida, H; Kawasaki, T; Masutani, S; Miya, A; Morimoto, O; Satomi, T; Shiozaki, K; Tatsuta, M; Tsuji, Y | 1 |
| Awane, Y; Maeshiro, T; Miyamoto, S; Umekita, N | 1 |
| Hamada, H; Hashimoto, M; Katsuki, Y; Kawata, S; Kon, H; Sasaki, R; Tomita, I; Tsuji, Y; Yasuda, T | 1 |
| Arai, K; Imai, R; Ito, K; Kojima, K; Muro, H; Nakagami, K; Nakajima, N; Nishimura, K; Onogawa, S; Suzuki, M; Tohyama, K; Umeda, Y | 1 |
| Dai, G; Liu, C; Zhang, X | 1 |
| Bounias, M; Kladny, J; Kruk, I; Lichszteld, K; Michalska, T | 1 |
| Ashley, S; Chang, JC; Gregory, RK; Powles, TJ | 1 |
| Sakata, Y; Tsushima, K | 1 |
| Denis, L | 1 |
| Casucci, D; Frati, L; Gulino, A; Rea, S; Recchia, F; Sica, G | 1 |
| Birch, BR; Cooper, AJ; Foley, SJ; Jennings, AM; Solomon, LZ | 1 |
| An, M; Hamada, E; Ikawa, M; Matsumoto, Y; Miura, T; Murata, M; Nakasato, S; Takagi, S; Terakado, H; Watanabe, K | 1 |
| Ishibashi, T; Kaneko, M; Kitada, H; Kobayashi, T; Kohyama, A; Kuwae, C; Minaguchi, R; Ohtsuka, H; Ono, I | 1 |
| Hasegawa, K; Ichikawa, T; Kawai, S; Kirihara, M; Kume, S; Maruo, H; Tominaga, S | 1 |
| Aoki, T; Ashizawa, T; Hirota, T; Katsumata, K; Kitamura, K; Koyanagi, Y; Misaka, T; Mori, Y; Murano, A; Murohashi, T; Sumi, T; Yamamoto, K; Yamashita, S | 1 |
| Aro, AR; Heikkinen, M; Hietanen, P; Holli, K; Huovinen, R; Joensuu, H; Suonio, E | 1 |
| Abe, T; Hashimoto, Y; Kojima, A; Mori, M; Nagamine, T; Sohara, N; Takagi, H; Takahashi, H | 1 |
| Hayashi, N; Inagaki, R; Ishii, Y; Muramatsu, I; Sakai, T; Taniguchi, T | 1 |
| Bellringer, J; Doherty, AP; Rogers, H; Stirling, R; Trendell-Smith, N | 1 |
| Chen, Z; Li, G; Liu, F | 1 |
| Chiba, T; Ito, K; Kojima, K; Nakajima, N; Seno, H | 1 |
| Chang, WJ; Chen, CH; Liaw, CC; Tsao, TC; Yang, CT | 1 |
| Dunst, J; Tanner, J | 1 |
| Arai, Y; Ariyoshi, Y; Itoh, K; Kumada, T; Nakamura, K; Tajima, K; Takayasu, Y | 1 |
| Asano, M; Higashi, S; Hosono, Y; Kane, T; Kato, C; Matsumoto, K; Sakoda, M; Sakumoto, H; Sumiyoshi, K; Takahahsi, T; Takahashi, M; Yamamoto, A | 1 |
| Aoki, T; Ito, K; Kasuya, K; Katayanagi, S; Koyanagi, Y; Sasaki, Y; Suzuki, K; Takagi, Y; Tsuchida, A; Yamazaki, T | 1 |
| Hirokawa, K; Miyamoto, T; Saiwai, S; Tashiro, T; Usuki, N | 1 |
| Bisagni, G; Boni, C; Ceci, G; Cocconi, G; De Lisi, V; Di Blasio, B; Morandi, P; Passalacqua, R; Savoldi, L; Zadro, A | 1 |
| Malmström, P | 1 |
| Balestreri, L; Morassut, S | 1 |
| Melekos, MD; Moutzouris, GD | 1 |
| Endo, S; Itakura, M; Minari, Y; Nio, Y; Tamura, K; Yamasawa, K; Yano, S | 1 |
| Duque, JL; Loughlin, KR | 1 |
| Chang, FY; Chau, GY; Chiang, JH; Huang, YH; Huo, TI; King, KL; Lee, SD; Lui, WY; Tsay, SH; Wu, JC | 1 |
| Danenberg, PV; Kornmann, M; Leder, GH; Link, KH; Pillasch, J | 1 |
| Ezawa, S; Fukuchi, T; Komuro, Y; Mikami, M; Mukai, M; Sakaiya, N; Tei, C | 1 |
| Baselli, EC; Greenberg, RE | 1 |
| Algeri, R; Barsanti, G; Bastiani, P; Fallai, C; Guarneri, A; Marzano, S; Neri, B; Pacini, P; Rinaldini, M; Tucci, E | 1 |
| Beger, HG; Butzer, U; Danenberg, KD; Danenberg, PV; Kornmann, M; Leder, G; Link, KH; Pillasch, J; Salonga, D; Sunelaitis, E | 1 |
| Ikeda, J; Takayasu, Y; Yamamoto, S | 1 |
| Fukushima, Y; Fuzita, J; Hata, S; Hayashida, H; Ikeda, K; Ishida, T; Kitada, M; Nakamura, T; Niinobu, T; Shibata, T; Shimano, T; Suzuki, R; Takahashi, Y; Takami, M; Tukahara, Y | 1 |
| Azama, T; Furukawa, J; Hashimoto, T; Katsumoto, Y; Nakaguchi, K; Okajima, S; Shingai, T; Sue, F; Takekuni, K; Yukawa, M | 1 |
| Akiyama, N; Ishizaki, M; Motegi, M; Nakajima, M; Osawa, H; Sasamoto, H; Tanaka, S; Wada, W | 1 |
| De Filippis, S; Pompili, PL; Rea, S; Recchia, F; Rosselli, M; Sica, G | 1 |
| Bafaloukos, D; Brountzos, EN; Kelekis, DA; Magoulas, D; Panagiotou, IE | 1 |
| Masters, JR | 1 |
| Majima, T; Nakajima, T; Nozu, S; Okayasu, K; Saitou, AY; Yagi, A | 1 |
| Hirakawa, K; Nakazawa, K; Nishihara, T; Nishino, H; Tamamori, Y; Tanaka, H; Yamada, N | 1 |
| Chung, NN; Hong, RL; Hsu, MM; Ko, JY; Lou, PJ; Lui, LT; Sheen, TS; Ting, LL; Wang, CC | 1 |
| Bono, AV; Brausi, M; de Balincourt, C; Hall, R; Mack, D; Oosterlinck, W; Sylvester, R | 1 |
| Dunst, J; Haensgen, G | 1 |
| Kaneko, M; Oguchi, S; Saida, T; Uhara, H | 1 |
| Ikeda, T; Kitajima, M; Tokura, H | 1 |
| Chu, DT; Li, JL; Qu, FL; Sun, Y; Zhang, XR | 1 |
| Kawarada, Y; Kitagawa, K; Matsumura, K; Nakatsuka, A; Takeda, K; Tanaka, N; Yamakado, K | 1 |
| Doki, Y; Fujiwara, Y; Inoue, M; Monden, M; Shiozaki, H; Tamura, S; Tsujinaka, T; Yano, M; Yasuda, T | 1 |
| Chen, Y; He, XF; Li, YH; Lu, W; Qiu, YR; Zeng, QL | 1 |
| Hamada, H; Katsuki, Y; Takada, J; Tsuji, Y | 2 |
| Esumi, K; Furukawa, H; Imamura, H; Inoue, Y; Ishida, H; Katoh, H; Kitani, K; Masuda, N; Masutani, S; Onishi, H; Shimizu, J; Tatsuta, M; Tomotsu, K; Tsuda, K; Usui, T | 1 |
| Xiao, QM; Zhang, WD; Zhou, JH | 1 |
| Akuta, K; Emoto, T; Kigami, Y; Kobayashi, H; Umeoka, S | 1 |
| Cai, L; Liao, Q; Wu, Y; Zhao, Y; Zhu, Y | 1 |
| Iwahashi, M; Nakamori, M; Nakamura, M; Yamaue, H | 1 |
| Maruyama, S | 1 |
| Hirakawa, K; Kosaka, K; Nishihara, T; Nishino, H; Ohira, M; Yamada, N | 1 |
| Furuse, J; Ishii, H; Nagase, M; Sato, T; Yonemoto, N; Yoshino, M | 1 |
| Hori, Y; Kiyosue, H; Komatsu, E; Matsumoto, A; Matsumoto, S; Mori, H; Tomonari, K; Wakisaka, M | 1 |
| Nishiura, K; Obata, H; Okugawa, T; Tabata, T; Tanaka, K; Toyoda, N; Yanoh, K | 1 |
| Chen, XM; Fu, L; Li, WK; Lin, HH; Luo, PF; Shao, PJ; Zhou, ZJ | 1 |
| Camaggi, CM; Cavallo, G; D'Angelo, R; Facchini, G; Fiore, F; Formato, R; Iaccarino, V; Iaffaioli, RV; Mantovani, G; Memoli, B; Petrella, G; Ricci, S; Rosato, G; Santangelo, M; Strocchi, E; Tortoriello, A | 1 |
| Ito, C; Kobayashi, M; Kozaka, K; Matsui, O; Minami, T; Miyayama, S; Notsumata, K; Shinmura, R; Takamatsu, S; Taki, K; Tanaka, N; Toya, D | 1 |
| Huang, WJ; Lin, TP; Murphy, GF; Pan, CC | 1 |
| Akimaru, K; Hirakata, A; Kato, S; Kawano, Y; Mamada, Y; Mineta, S; Tajiri, T; Taniai, N; Yokomuro, S; Yoshida, H | 1 |
| Cai, L; Cui, NJ; Gu, MF; Li, GH; Li, JQ; Li, Q; Liu, H; Liu, MZ; Wang, XS; Zhang, YQ | 1 |
| Asahara, S; Fujita, N; Fujita, R; Ikari, T; Kamei, A; Sato, E; Shimizu, M; Takano, K | 1 |
| Bernardeschi, P; Cantore, M; De Simone, M; Dentico, P; Fiorentini, G; Guadagni, S; Poddie, DB; Rossi, G; Rossi, S; Tumolo, S; Valori, VM | 1 |
| Ahn, SH; Cho, KB; Choi, JS; Chung, WJ; Hwang, JS; Hwang, JY; Jang, BK; Kim, GC; Kim, YH; Kwon, JH; Kwon, KM; Park, KS | 1 |
| Jansen, CF; Schalken, JA; van der Heijden, AG; Verhaegh, G; Witjes, JA | 1 |
| Edgren, M; Ginman, C; Kälkner, KM; Nilsson, S; Nordström, B; Ryberg, M; Strang, P; Westlin, JE; Zimmermann, R | 1 |
| Amy, JJ; Coomans, D; Michielsen, D; Storme, G; Wyndaele, JJ | 1 |
| Araki, K; Haruno, M; Ogawa, Y; Sakai, K; Shimamura, R; Tanaka, H | 1 |
| Hale, K; Lamm, DL; McGee, WR | 1 |
| Koulentianos, E; Polyzos, A; Sfikakis, P; Tzianoumis, L | 1 |
| Alexopoulos, A; Papacharalambous, A; Rigatos, G; Scartsilas, C; Stavrakakis, J; Stavrinidis, E | 1 |
| Chen, RC; Chen, WT; Chiang, LC; Lii, JM; Tu, HY | 1 |
| Liu, FY; Shao, RH; Wang, MQ; Wang, ZP; Wang, ZQ; Ye, HY | 1 |
| Bonacina, P; Butti, A; Cappoli, S; Esposito, N; Invernizzi, S; Librizzi, A; Locatelli, G; Trinchieri, A | 1 |
| Hoki, M; Hori, S; Ito, T; Iwase, K; Kainuma, S; Kanou, T; Mizuno, H; Mizushima, T; Nakamori, Y; Ozawa, H; Souma, Y; Sugiura, T; Yamanaka, H | 1 |
| Eifel, PJ | 1 |
| Cooper, AJ; Harris, NM; Lwaleed, BA; Mackie, SJ; Sharma, DM | 1 |
| Nagaoka, S; Okabe, Y; Ono, N; Saito, F; Sata, M; Suga, H; Toyonaga, A; Tsuruta, O | 1 |
| Chen, L; Gan, L; Lai, YQ; Li, M; Liu, G; Na, YQ; Yin, ZF; Yuan, YM | 1 |
| Burgués, JP; Gómez, L; Jiménez-Cruz, JF; Ozonas, M; Pontones, JL; Vera, CD | 1 |
| Li, DP; Liu, YL; Song, XR; Wang, XW; Wei, L | 1 |
| Bartoletti, R; Cai, T; Farina, U; Mazzoli, S; Melone, F; Mondaini, N | 1 |
| Ishiguro, A; Itoh, J; Munakata, A; Munakata, M; Sakata, Y; Shitara, K; Suzuki, K; Takahata, T | 1 |
| Cooper, AJ; Featherstone, JM; Lwaleed, BA; Speers, AG | 1 |
| Beltrami, P; Cazzoletti, L; Ruggera, L; Schiavone, D; Zattoni, F | 1 |
| Arnedos, M; Ashley, S; Johnston, S; Nerurkar, A; Popat, S; Sirohi, B; Smith, IE; Walsh, G | 1 |
| Okita, K; Saeki, I; Sakaida, I; Shiraishi, R; Terai, S; Uchida, K; Yamaguchi, Y; Yamasaki, T | 1 |
| Feng, B; Liang, SN; Liu, LL; Su, HY; Xu, K; Zhao, GS | 1 |
| Fuse, H; Imamura, T; Kaji, K; Oishi, N; Okumura, A | 1 |
| Dong, S; Sun, ZC; Xiao, XS; Xu, LC; Ye, XD; Yuan, Z | 1 |
| Birare, N; Cooper, AJ; Lwaleed, BA | 1 |
| Chou, YH; Huang, CH; Ke, HL; Li, CC; Wu, WJ; Yang, YH | 1 |
| Nieder, AM | 1 |
| Aoki, T; Hamada, H; Katsuki, Y; Kenno, S; Takada, J | 1 |
| Kynaston, H; Mason, MD; Shelley, MD | 1 |
| Arii, S; Ikai, I; Kojiro, M; Kudo, M; Makuuchi, M; Matsuyama, Y; Takayasu, K | 1 |
| Baba, Y; Hiramine, Y; Hiwaki, T; Imamura, Y; Sho, Y; Tahara, K; Tsubouchi, H; Uto, H | 1 |
| Chen, Y; Li, H; Liu, DZ; Yan, D; Zeng, HY; Zhou, CW | 1 |
| Hayami, S; Ozawa, S; Shigekawa, Y; Tani, M; Uchiyama, K; Ueno, M; Yamaue, H | 1 |
| Cao, M; Chen, HG; Ma, CK; Ma, J; Xue, W | 1 |
| Chen, SH; Chuang, WL; Hsieh, MY; Lin, ZY | 1 |
| Berry, FB; Buckley, NE; Crawford, NT; Gorski, JJ; Harkin, DP; Kennedy, RD; Mullan, PB; Tkocz, D | 1 |
| Chen, SH; Chuang, WL; Hsieh, MY; Huang, CF; Lin, CI; Lin, ZY | 1 |
| Hashimoto, M; Matsui, O; Miyayama, S; Shibata, Y; Toshima, F; Tsuji, K; Yamashiro, M; Yoshida, M | 1 |
| Kang, WM; Ma, ZQ; Wang, J; Yu, JC | 1 |
| Ikoma, A; Kawai, N; Minamiguchi, H; Nakai, M; Nakata, K; Sahara, S; Sanda, H; Sato, M; Shirai, S; Sonomura, T; Tanaka, T | 1 |
| Anker, G; Chrisanthar, R; Knappskog, S; Leirvaag, B; Lundgren, S; Løkkevik, E; Lønning, PE; Miletic, H; Mjaaland, I; Risberg, T; Østenstad, B | 1 |
| Hatamaru, K; Henmi, S; Inuzuka, T; Kimura, T; Kita, R; Matsuda, F; Nakajima, J; Nasu, A; Nishikawa, H; Osaki, Y; Saito, S; Sakamoto, A; Takeda, H | 1 |
| Hu, Y; Li, H; Li, N; Zhou, Y | 1 |
| Ooi, H; Ozaki, T; Seki, H | 1 |
| Chen, MS; Fang, WQ; Guo, RP; Li, Y; Lin, XJ; Lu, LG; Luo, J; Shi, M; Xu, L; Zhang, YQ; Zou, RH | 1 |
| Arimoto, A; Kimura, T; Kita, R; Nishikawa, H; Osaki, Y; Wakasa, T | 1 |
| Chan, MW; Chen, LG; Chen, SY; Hsieh, HY; Hsu, CD; Lin, MY; Lu, CC; Shen, CH | 1 |
| Duan, F; Fan, QS; Liu, FY; Song, P; Wang, MQ; Wang, Y | 1 |
| Alfred Witjes, J; Arentsen, HC; Falke, J; Høgset, A; Oosterwijk, E | 1 |
| Kimura, T; Kita, R; Komekado, H; Nasu, A; Nishiguchi, S; Nishijima, N; Nishikawa, H; Ohara, Y; Osaki, Y; Saito, S; Sakamoto, A; Takeda, H | 1 |
| Namikawa, K; Oashi, K; Omata, W; Tanaka, R; Tsutsumida, A; Yamamoto, Y; Yamazaki, N | 1 |
| Arends, TJ; van der Heijden, AG; Witjes, JA | 1 |
| Chen, CC; Jiang, RS; Liang, KL; Lin, JC; Lin, PJ; Liu, YC; Shih, YT; Twu, CW; Wang, WY; Wu, CT | 1 |
| Endo, H; Inoue, M; Nakayama, M; Nishimura, K; Nonomura, N; Okuyama, H; Yoshida, T | 1 |
| Huang, J; Li, B; Li, Q; Shen, J; Wang, J; Yuan, Y; Zheng, Y; Zou, R | 1 |
| Cheng, Y; Deng, X; Li, X; Liu, X; Lu, Q; Qin, C; Yang, X; Yin, C; Zhang, X; Zhao, R | 1 |
| Decaestecker, K; Lumen, N; Oosterlinck, W; Ringoir, A | 1 |
| Ali-El-Dein, B; Babjuk, M; Birtle, A; De Nunzio, C; Gudjonsson, S; Holmang, S; Inman, BA; Kaasinen, E; N'Dow, J; Oddens, JR; Okamura, K; Oosterlinck, W; Solsona, E; Sydes, MR; Sylvester, RJ; Tatar, CA | 1 |
| Ohi, H; Ozaki, T; Seki, H; Yabusaki, H | 1 |
| Cheng, Y; Deng, X; Li, X; Liu, X; Lu, Q; Qin, C; Yang, X; Yin, C; Zhao, R | 1 |
| Cui, H; Jiang, R; Li, X; Lin, X; Liu, C; Tao, R; Tian, S; Zhuang, H; Zhuo, C | 1 |
| Boorjian, SA; Lu, DD; Raman, JD | 1 |
| Chang, X; Miao, C; Ni, H; Tang, Q; Wu, C; Zhang, J; Zhou, X | 1 |
| Chung, JI; Hwang, H; Kim, TS; Noh, GH | 1 |
| Hori, A; Hori, S; Kennoki, N; Yuki, T | 1 |
| Cozar-Olmo, JM; Fernandez-Gomez, JM; Juárez, A; Martínez-Piñeiro, L; Palou, J; Unda-Urzaiz, M | 1 |
| Chen, M; Guo, R; He, M; Lai, J; Li, Q; Shen, J; Shi, M; Tan, G; Wei, W; Zhang, Y; Zou, R | 1 |
| Namikawa, K; Takahashi, A; Tsutsui, K; Yamazaki, N | 1 |
| Alsyouf, M; Groegler, J; Hu, B; Pierorazio, P | 1 |
| Audenet, F; Brunelle, S; Compérat, E; Houédé, N; Lanz, C; Larré, S; Masson-Lecomte, A; Méjean, A; Neuzillet, Y; Pignot, G; Rollin, P; Roumiguié, M; Rouprêt, M; Xylinas, E | 1 |
| Allory, Y; Audenet, F; Leon, P; Loriot, Y; Masson-Lecomte, A; Neuzillet, Y; Pradère, B; Roumiguié, M; Roupret, M; Saint, F; Seisen, T; Traxer, O; Xylinas, E | 1 |
| Budaya, TN; Daryanto, B; Purnomo, AF; Seputra, KP | 1 |
| Brummelhuis, ISG; Crezee, J; Witjes, JA | 1 |
| Ambite, I; Babjuk, M; Cavalera, M; Chaudhuri, A; Esmaeili, P; Hien, TT; Sabari, S; Svanborg, C; Wan, MLY | 1 |
26 review(s) available for mitomycin and epirubicin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Cytotoxic treatment of metastatic breast cancer. Which drugs and drug combinations to use?
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Melphalan; Methotrexate; Mitomycin; Mitoxantrone; Neoplasm Metastasis; Vincristine | 1992 |
Complications of intravesical chemotherapy.
Topics: Administration, Intravesical; Antineoplastic Agents; Carcinoma, Transitional Cell; Doxorubicin; Epirubicin; Ethoglucid; Humans; Mitomycin; Mitoxantrone; Thiotepa; Urinary Bladder Neoplasms | 1992 |
[Combined chemotherapy with the FEM protocol in advanced gastric cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Neoplasm Staging; Stomach Neoplasms | 1989 |
[Chemotherapy for advanced adenocarcinoma of the skin: experience with combination chemotherapy and a review of the literature].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Administration Schedule; Epirubicin; Fluorouracil; Humans; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Paget Disease, Extramammary; Skin Neoplasms; Sweat Gland Neoplasms; Vincristine | 1997 |
[Treatment of recurrent gastric cancer].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Fluorouracil; Humans; Immunologic Factors; Irinotecan; Liver Neoplasms; Lymphatic Metastasis; Methotrexate; Mitomycin; Neoplastic Cells, Circulating; Peritoneal Neoplasms; Stomach Neoplasms | 1998 |
Improved patient outcomes with BCG immunotherapy vs. chemotherapy - Swedish and worldwide experience.
Topics: Administration, Intravesical; Antibiotics, Antineoplastic; BCG Vaccine; Chemotherapy, Adjuvant; Combined Modality Therapy; Doxorubicin; Epirubicin; Humans; Mitomycin; Sweden; Thiotepa; Treatment Outcome; Urinary Bladder Neoplasms | 2000 |
[Hepatic chemoembolization in a patient allergic to iodinated contrast media: the use of Gd-DTPA].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoembolization, Therapeutic; Contrast Media; Drug Hypersensitivity; Epirubicin; Female; Gadolinium DTPA; Humans; Iodized Oil; Liver; Liver Neoplasms; Magnetic Resonance Angiography; Mitomycin | 1999 |
Intravesical therapy of superficial bladder cancer.
Topics: Administration, Intravesical; Antineoplastic Agents; Doxorubicin; Epirubicin; Humans; Immunotherapy; Interferons; Mitomycin; Mitoxantrone; Mycobacterium bovis; Thiotepa; Urinary Bladder Neoplasms | 2000 |
An overview of the treatment of superficial bladder cancer. Intravesical chemotherapy.
Topics: Administration, Intravesical; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Epirubicin; Ethoglucid; Humans; Immunotherapy; Mitomycin; Thiotepa; Urinary Bladder Neoplasms | 2000 |
Intravesical therapy for superficial bladder cancer.
Topics: Adjuvants, Immunologic; Administration, Intravesical; Antibiotics, Antineoplastic; Anticarcinogenic Agents; Antineoplastic Agents; Carcinoma, Transitional Cell; Doxorubicin; Epirubicin; Humans; Interferons; Mitomycin; Mycobacterium bovis; Neoplasm, Residual; Photochemotherapy; Photosensitizing Agents; Thiotepa; Urinary Bladder Neoplasms | 2000 |
[A case of gastric cancer with multiple liver metastases that were completely responsive to hepatic arterial infusion chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Epirubicin; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Remission Induction; Stomach Neoplasms | 2001 |
Simultaneous radiochemotherapy in cervical cancer: recommendations for chemotherapy.
Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Middle Aged; Mitomycin; Multicenter Studies as Topic; Neoplasm Metastasis; Neoplasm Recurrence, Local; Postoperative Care; Radiation-Sensitizing Agents; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Uterine Cervical Neoplasms | 2001 |
[Intra-arterial infusion chemotherapy for breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Lung Neoplasms; Mitomycin | 2002 |
The treatment of advanced non-small-cell lung cancer (NSCLC)--overseas updated and local experiences.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials, Phase III as Topic; Epirubicin; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Survival Rate | 2002 |
[Complications of hepatic artery chemotherapy for liver metastases in colorectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Arterial Occlusive Diseases; Cholangitis, Sclerosing; Cisplatin; Colorectal Neoplasms; Epirubicin; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin; Nausea; Peptic Ulcer; Vomiting | 2003 |
Bladder cancer: current optimal intravesical treatment.
Topics: Adjuvants, Immunologic; Administration, Intravesical; Antineoplastic Agents; BCG Vaccine; Cystectomy; Doxorubicin; Drug Administration Schedule; Epirubicin; Humans; Interferon-alpha; Mitomycin; Neoplasm Recurrence, Local; Nurse's Role; Patient Selection; Risk Factors; Salvage Therapy; Survival Rate; Thiotepa; Treatment Failure; United States; Urinary Bladder Neoplasms | 2005 |
Concurrent chemotherapy and radiation therapy as the standard of care for cervical cancer.
Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Epirubicin; Female; Fluorouracil; Humans; Mitomycin; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome; Uterine Cervical Neoplasms | 2006 |
[Arterial infusion chemotherapy for patients with advanced pancreatic cancer].
Topics: Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Celiac Artery; Deoxycytidine; Drug Administration Schedule; Epirubicin; Fluorouracil; Gemcitabine; Humans; Infusions, Intra-Arterial; Mesenteric Artery, Superior; Mitomycin; Pancreatic Neoplasms; Quality of Life; Radiography; Survival Rate | 2006 |
Intravesical therapy for superficial bladder cancer: a systematic review of randomised trials and meta-analyses.
Topics: Administration, Intravesical; Antineoplastic Agents; BCG Vaccine; Combined Modality Therapy; Epirubicin; Humans; Immunotherapy; Meta-Analysis as Topic; Mitomycin; Randomized Controlled Trials as Topic; Urinary Bladder Neoplasms | 2010 |
Partial hepatectomy for liver metastases from nasopharyngeal carcinoma: a comparative study and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Chemoembolization, Therapeutic; Chemotherapy, Adjuvant; Disease Progression; Disease-Free Survival; Epirubicin; Ethiodized Oil; Female; Follow-Up Studies; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate | 2014 |
Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma
Topics: Administration, Intravesical; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Disease Progression; Doxorubicin; Epirubicin; Humans; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Staging; Randomized Controlled Trials as Topic; Risk Factors; Survival Rate; Thiotepa; Time Factors; Urinary Bladder Neoplasms | 2016 |
Evaluating the efficacy and safety of intravesical chemotherapies for non-muscle invasive bladder cancer: a network meta-analysis.
Topics: Administration, Intravesical; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; BCG Vaccine; Deoxycytidine; Disease Progression; Epirubicin; Female; Gemcitabine; Humans; Isoniazid; Male; Middle Aged; Mitomycin; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Odds Ratio; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms | 2016 |
Assessing the Feasibility of Replacing Standard-Dose Bacillus Calmette-Guérin Immunotherapy with Other Intravesical Instillation Therapies in Bladder Cancer Patients: A Network Meta-Analysis.
Topics: Epirubicin; Female; Humans; Immunotherapy; Male; Mitomycin; Mycobacterium bovis; Urinary Bladder Neoplasms | 2017 |
Chemoablation in Urothelial Carcinoma: A Systematic Review and Future Perspectives.
Topics: Administration, Intravesical; Antineoplastic Agents; Aziridines; BCG Vaccine; Carcinoma, Transitional Cell; Clinical Trials as Topic; Cystoscopy; Deoxycytidine; Epirubicin; Ethanol; Forecasting; Gemcitabine; Humans; Indolequinones; Injections, Intralesional; Interferon-alpha; Interleukin-2; Mitomycin; Urinary Bladder Neoplasms; Urothelium | 2020 |
Comparison Between Intravesical Chemotherapy Epirubicin and Mitomycin-C after TURB vs TURB Alone With Recurrence Rate of Non-Muscle Invasive Bladder Cancer: Meta-Analysis.
Topics: Administration, Intravesical; Carcinoma, Transitional Cell; Epirubicin; Female; Humans; Male; Mitomycin; Neoplasm Recurrence, Local; Randomized Controlled Trials as Topic; Urinary Bladder Neoplasms | 2022 |
51 trial(s) available for mitomycin and epirubicin
| Article | Year |
|---|---|
Randomized trial of adjuvant chemotherapy for operable breast cancer comparing i.v. CMF to an epirubicin-containing regimen [see comment].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Injections, Intravenous; Methotrexate; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Thiotepa; Vincristine; Vindesine | 1992 |
[Prospective randomized multicenter phase III study of treatment of hormone refractory prostatic cancer: mitomycin C vs. 4-epirubicin vs. estramustine phosphate].
Topics: Epirubicin; Estramustine; Humans; Male; Mitomycin; Prospective Studies; Prostatic Neoplasms | 1992 |
4'-epidoxorubicin versus mitomycin C intravesical chemoprophylaxis of superficial bladder cancer.
Topics: Administration, Intravesical; Aged; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Epirubicin; Female; Follow-Up Studies; Humans; Male; Mitomycin; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms | 1992 |
[Treatment of advanced pancreatic cancer with 5-fluorouracil, 4-epidoxorubicin and mitomycin C (FEM II). From the Chemotherapy of Gastrointestinal Tumors Group].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Epirubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Palliative Care; Pancreatic Neoplasms; Survival Rate | 1990 |
Randomised trial of epirubicin alone versus 5-fluorouracil, epirubicin and mitomycin C in locally advanced and metastatic carcinoma of the pancreas.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Fluorouracil; Follow-Up Studies; Humans; Mitomycin; Mitomycins; Neoplasm Metastasis; Pancreatic Neoplasms | 1991 |
Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Protocols; Epirubicin; Female; Humans; Lymph Node Excision; Mastectomy; Methotrexate; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy Dosage; Thiotepa; Vincristine; Vindesine | 1991 |
Bleomycin, vincristine, mitomycin and cisplatin alternated with cyclophosphamide, 4'-epidoxorubicin and procarbazine in advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Procarbazine; Vincristine | 1988 |
Dose escalation and split course of 4-epidoxorubicin in combination chemotherapy (FEM II) of advanced gastric carcinoma. A phase-II trail of the 'Chemotherapiegruppe Gastrointestinaler Tumoren (CGT)'.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Evaluation; Epirubicin; Female; Fluorouracil; Gastrectomy; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Multicenter Studies as Topic; Neoplasm Metastasis; Stomach Neoplasms | 1989 |
[Chemotherapy of breast cancers. Coordinated evolution of therapeutic schemes from 1975 to 1985].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Methotrexate; Mitomycin; Mitomycins; Thiotepa; Vincristine; Vindesine | 1986 |
Combination chemotherapy with epirubicin and mitomycin C as first-line treatment in advanced breast cancer.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Epirubicin; Female; Humans; Leukopenia; Middle Aged; Mitomycin; Neoplasm Metastasis; Palliative Care; Time Factors | 1994 |
Combination chemotherapy of 5-fluorouracil, epidoxorubicin and mitomycin C in the palliative treatment of locally advanced and/or metastatic adenocarcinoma of the stomach.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Palliative Care; Stomach Neoplasms | 1994 |
Combined transarterial targeting locoregional immunotherapy-chemotherapy for patients with unresectable hepatocellular carcinoma: a new alternative for an old problem.
Topics: Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Hepatocellular; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Interferon-gamma; Interleukin-2; Leucovorin; Liver; Liver Neoplasms; Male; Middle Aged; Mitomycin; Necrosis; Pilot Projects; Spleen; Survival Rate; Tomography, Emission-Computed | 1995 |
[A prospective randomized clinical trial comparing intra-arterial chemotherapy alone and when combined with hyperthermia for metastatic liver cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Hyperthermia, Induced; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Stomach Neoplasms | 1995 |
[Evaluation of local treatment for unresectable primary liver tumor].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Epirubicin; Female; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Prognosis; Proportional Hazards Models; Retrospective Studies; Survival Rate | 1994 |
[Evaluation of arterial infusion chemotherapy for advanced gallbladder cancer using implantable port].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Gallbladder Neoplasms; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Male; Mitomycin; Treatment Outcome | 1994 |
[Intra-arterial chemotherapy for the treatment of advanced hepatocellular carcinoma through implantable port (reservoir)].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Injections, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Survival Analysis | 1994 |
Fluorouracil, doxorubicin, and mitomycin combination versus PELF chemotherapy in advanced gastric cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Mitomycin; Prospective Studies; Remission Induction; Stomach Neoplasms; Survival Analysis; Treatment Outcome | 1994 |
[Efficacy of FEM (5-fluorouracil, epirubicin, mitomycin C) therapy for resected advanced gastric cancer. Ehime Gastric Cancer Study Meeting].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Administration Schedule; Epirubicin; Fluorouracil; Gastrectomy; Humans; Japan; Mitomycin; Stomach Neoplasms; Survival Rate | 1993 |
[A randomized trial of intrahepatic infusion chemotherapy for unresectable colorectal liver metastases. Sendai Study Group].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Survival Rate | 1993 |
[The efficacy of intra-arterial infusion chemotherapy in patients with non-resectable liver metastasis from colorectal cancer--a randomized study comparing FAM versus FEM].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Survival Rate | 1993 |
Comparison of single-agent epirubicin and 5-fluorouracil/epirubicin/mitomycin in patients with advanced adenocarcinoma of the pancreas.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Neoplasm Staging; Pancreatic Neoplasms | 1993 |
Chemoresection in Ta-T1 bladder cancer. Members of the EORTC Genito-Urinary Group.
Topics: Administration, Intravesical; Aged; Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Drug Administration Schedule; Epirubicin; Female; Humans; Male; Mitomycin; Treatment Outcome; Urinary Bladder Neoplasms | 1996 |
5-Fluorouracil, epirubicin, and mitomycin C versus 5-fluorouracil, epirubicin, mitomycin C, and leucovorin in advanced gastric carcinoma. A randomized trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Epirubicin; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Stomach Neoplasms; Survival Rate | 1996 |
[Clinical effect of intra-arterial carboplatin-combined chemotherapy for advanced uterine cervical cancer and increased tissue platinum levels with Lipo PGE1 administration before chemotherapy].
Topics: Adenocarcinoma; Adult; Aged; Alprostadil; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Cervix Uteri; Chemotherapy, Adjuvant; Epirubicin; Etoposide; Female; Humans; Iliac Artery; Infusions, Intra-Arterial; Infusions, Intravenous; Middle Aged; Mitomycin; Platinum; Uterine Cervical Neoplasms; Vindesine | 1996 |
Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST pi.
Topics: Adult; Aged; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Epirubicin; Female; Glutathione Transferase; Humans; Immunohistochemistry; Methotrexate; Middle Aged; Mitomycin; Neoplasm Proteins; Prognosis; Proteins; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Thiotepa; Trefoil Factor-1; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Vincristine; Vindesine | 1996 |
[Evaluation of intra-arterial infusion chemotherapy for liver metastasis from gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Mitomycin; Stomach Neoplasms; Survival Rate | 1997 |
A randomised trial of six versus twelve courses of chemotherapy in metastatic carcinoma of the breast.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Hematologic Diseases; Humans; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Neoplasm Metastasis; Palliative Care; Prospective Studies; Survival Rate; Vincristine | 1997 |
European Organization for Research and Treatment of Cancer (EORTC) prostate cancer trials, 1976-1996.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Castration; Cyproterone Acetate; Diethylstilbestrol; Doxorubicin; Epirubicin; Estramustine; Flutamide; Humans; Imidazoles; Male; Medroxyprogesterone Acetate; Methotrexate; Mitomycin; Neoplasms, Hormone-Dependent; Procarbazine; Prostatic Neoplasms; Vindesine | 1998 |
Advanced carcinoma of the pancreas: phase II study of combined chemotherapy, beta-interferon, and retinoids.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Diterpenes; Epirubicin; Female; Fluorouracil; Humans; Interferon-beta; Leucovorin; Male; Middle Aged; Mitomycin; Pancreatic Neoplasms; Retinyl Esters; Survival Rate; Vitamin A | 1998 |
Combination chemotherapy versus single-agent therapy as first- and second-line treatment in metastatic breast cancer: a prospective randomized trial.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Mitomycin; Mitomycins; Prospective Studies; Quality of Life; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Vinblastine | 1998 |
[Influence of preoperative on gastric cancer tissues and cells].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Preoperative Care; Stomach Neoplasms | 1997 |
[Polychemotherapy versus monotherapy in metastatic breast carcinoma].
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Progression; Epirubicin; Female; Humans; Mitomycin; Neoplasm Metastasis; Quality of Life; Treatment Outcome | 1999 |
Phase II study of combined administration of 5-fluorouracil, epirubicin and mitomycin-C by hepatic artery infusion in patients with liver metastases of gastric cancer.
Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Japan; Liver Neoplasms; Male; Middle Aged; Mitomycin; Stomach Neoplasms; Survival Analysis; Treatment Outcome | 1999 |
[Arterial infusion therapy with implantable port for inoperable hepatobiliary tumors].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Cisplatin; Colonic Neoplasms; Drug Administration Schedule; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Prognosis; Stomach Neoplasms | 1999 |
Three new active cisplatin-containing combinations in the neoadjuvant treatment of locally advanced and locally recurrent breast carcinoma: a randomized phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Epirubicin; Etoposide; Female; Humans; Leucovorin; Methotrexate; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Vincristine | 1999 |
Prospective case-controlled trial of adjuvant chemotherapy after resection of hepatocellular carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Case-Control Studies; Chemotherapy, Adjuvant; Epirubicin; Female; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Prospective Studies; Survival Rate | 2000 |
FEC (5-fluorouracil, epidoxorubicin and cyclophosphamide) versus EM (epidoxorubicin and mitomycin-C) with or without lonidamine as first-line treatment for advanced breast cancer. A multicentric randomised study. Final results.
Topics: Adult; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Mitomycin; Neoplasm Metastasis; Survival Analysis; Treatment Outcome | 2000 |
Thymidylate synthase quantitation and in vitro chemosensitivity testing predicts responses and survival of patients with isolated nonresectable liver tumors receiving hepatic arterial infusion chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Female; Fluorouracil; Folic Acid; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitoxantrone; Predictive Value of Tests; Prospective Studies; Thymidylate Synthase; Treatment Outcome; Tumor Stem Cell Assay | 2000 |
Phase II study of epirubicin, mitomycin C, and 5-fluorouracil in hormone-refractory prostatic carcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Epirubicin; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Rate | 2001 |
Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Analysis; Taiwan; Treatment Outcome | 2001 |
Effect of dosage of anticancer agents during transcatheter arterial chemoembolization on T cell subsets in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; T-Lymphocyte Subsets | 2002 |
Stop-flow technique for loco-regional delivery of high dose chemotherapy in the treatment of advanced pelvic cancers.
Topics: Adolescent; Adult; Aged; Anthracyclines; Antibiotics, Antineoplastic; Chemotherapy, Cancer, Regional Perfusion; Colorectal Neoplasms; Doxorubicin; Epirubicin; Female; Humans; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Staging; Pelvic Neoplasms; Treatment Outcome | 2004 |
[External radiation and combined transcatheter arterial chemoembolization for unresectable primary liver cancer].
Topics: Adult; Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Epirubicin; Female; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Particle Accelerators; Survival Rate; Treatment Outcome | 2005 |
Hepatic intra-arterial chemotherapy (HIAC) of high dose mitomycin and epirubicin combined with caval chemofiltration versus prolonged low doses in liver metastases from colorectal cancer: a prospective randomized clinical study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Epirubicin; Filtration; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin; Prospective Studies; Survival Rate | 2004 |
Palliation of bone pain in prostate cancer using chemotherapy and strontium-89. A randomized phase II study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Double-Blind Method; Epirubicin; Fluorouracil; Humans; Male; Mitomycin; Pain; Pain Measurement; Palliative Care; Prostatic Neoplasms; Radiopharmaceuticals; Severity of Illness Index; Strontium; Treatment Outcome | 2005 |
Are prostate biopsies mandatory in patients with prostate-specific antigen increase during intravesical immuno- or chemotherapy for superficial bladder cancer?
Topics: Aged; Antibiotics, Antineoplastic; BCG Vaccine; Biopsy; Drug Monitoring; Epirubicin; Humans; Immunotherapy; Male; Middle Aged; Mitomycin; Prospective Studies; Prostate; Prostate-Specific Antigen; Prostatitis; Unnecessary Procedures; Urinary Bladder Neoplasms | 2008 |
[Evaluation of the efficacy and safety of intravesical instillation with gemcitabine after first-line intravesical chemotherapy failure in the treatment of non-muscle-invasive bladder cancer].
Topics: Administration, Intravesical; Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Camptothecin; Deoxycytidine; Disease-Free Survival; Dose-Response Relationship, Drug; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Male; Middle Aged; Mitomycin; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms | 2011 |
Potential risk factors for the reactivation of the replication of hepatitis B and C viruses after transcatheter arterial chemoembolization of hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; DNA, Viral; Epirubicin; Female; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Leukocyte Count; Liver Neoplasms; Male; Middle Aged; Mitomycin; Odds Ratio; Risk Factors; RNA, Viral; ROC Curve; Viral Load; Virus Activation; Virus Replication | 2011 |
Prospective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti-cancer drugs (epirubicin, cisplatin, mitomycin c, 5-fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Angiography; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chi-Square Distribution; Cisplatin; Contrast Media; Endpoint Determination; Epirubicin; Female; Fluorouracil; Humans; Iohexol; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Mitomycin; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer.
Topics: Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Ataxia Telangiectasia Mutated Proteins; Breast Neoplasms; Cell Cycle Proteins; Checkpoint Kinase 2; Cohort Studies; DNA-Binding Proteins; Doxorubicin; Drug Resistance, Neoplasm; Epirubicin; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Mitomycin; Mutation; Paclitaxel; Predictive Value of Tests; Promoter Regions, Genetic; Prospective Studies; Protein Serine-Threonine Kinases; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2012 |
Roles played by chemolipiodolization and embolization in chemoembolization for hepatocellular carcinoma: single-blind, randomized trial.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; China; Cyclobutanes; Disease-Free Survival; Embolization, Therapeutic; Epirubicin; Ethiodized Oil; Female; Gelatin Sponge, Absorbable; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Organoplatinum Compounds; Single-Blind Method; Treatment Outcome | 2013 |
169 other study(ies) available for mitomycin and epirubicin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water | 2010 |
[Retrospective survey of pharmacologic tolerance in the prevention of neoplastic recurrence of superficial urothelioma].
Topics: Administration, Intravesical; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Humans; Interferons; Mitomycin; Neoplasm Recurrence, Local; Retrospective Studies; Urinary Bladder Neoplasms | 1992 |
[A case of hepatocellular carcinoma responding to intraarterial infusion of epirubicin and mitomycin C].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Epirubicin; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin | 1992 |
Mitomycin C plus vindesine or cisplatin plus epirubicin in previously treated patients with symptomatic advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Vindesine | 1992 |
Analysis of the four combination chemotherapies in non-small cell lung cancer treated at Maharaj Nakorn Chiang Mai Hospital.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Mitomycin; Survival Rate; Vinblastine | 1992 |
Hepatocellular carcinoma and transcatheter oily chemoembolization in Thailand.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Gelatin Sponge, Absorbable; Humans; Incidence; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Mitomycin; Survival Rate; Thailand | 1992 |
[Repeated arterial infusion chemotherapy for inoperable hepatocellular carcinoma using implantable drug delivery system].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Mitomycin; Survival Rate | 1992 |
Potentiation of topoisomerase I and II inhibitors cell killing by tumor necrosis factor: relationship to DNA strand breakage formation.
Topics: Camptothecin; Cell Death; Cisplatin; DNA Damage; DNA, Neoplasm; Drug Synergism; Epirubicin; Etoposide; Female; Humans; Mitomycin; Ovarian Neoplasms; Recombinant Proteins; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1992 |
Xenotransplantation of alpha-fetoprotein-producing gastric cancers into nude mice. Characteristics and responses to chemotherapy.
Topics: alpha-Fetoproteins; Animals; Antineoplastic Agents; Cisplatin; Doxorubicin; Epirubicin; Flow Cytometry; Fluorouracil; Humans; Immunohistochemistry; Mice; Mice, Inbred BALB C; Mice, Nude; Mitomycin; Neoplasm Transplantation; Paraneoplastic Endocrine Syndromes; Stomach Neoplasms | 1992 |
Diminished genotoxicity of mitomycin C and farmorubicin included in polybutylcyanoacrylate nanoparticles.
Topics: Animals; Bone Marrow; Drug Carriers; Enbucrilate; Epirubicin; Female; Liver; Maternal-Fetal Exchange; Mice; Micronuclei, Chromosome-Defective; Micronucleus Tests; Mitomycin; Mutagenicity Tests; Mutagens; Pregnancy; Salmonella typhimurium | 1992 |
The role of three cisplatin-based chemotherapy regimens in the treatment of advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cyclophosphamide; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Retrospective Studies; Vincristine; Vindesine | 1992 |
[Successful treatment of adenocarcinoma of the lung with bone metastases by combined chemotherapy with epirubicin, mitomycin C and carboplatin].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Epirubicin; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin | 1992 |
Chemotherapy of solid tumors in private practice in Malaysia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Fluorouracil; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Malaysia; Methotrexate; Mitomycin; Nasopharyngeal Neoplasms; Neoplasms; Private Practice | 1992 |
[Intermittent intra-arterial infusion chemotherapy using implantable reservoir for the treatment of hepatic metastasis].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Infusion Pumps, Implantable; Liver Neoplasms; Male; Middle Aged; Mitomycin; Survival Rate | 1992 |
[Treatment of liver metastases from gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Gastrectomy; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Prognosis; Stomach Neoplasms | 1992 |
[A pharmacokinetic study of intra-arterial chemotherapy for prophylactic treatment of liver metastasis after hepatectomy for liver cancer].
Topics: Chemotherapy, Adjuvant; Doxorubicin; Epirubicin; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Liver; Liver Neoplasms; Mitomycin; Neoplasm Recurrence, Local; Postoperative Care | 1992 |
[Evaluation of repeated hepatic dearterialization combined with intra-arterial infusion chemotherapy of unresectable primary or secondary cancer of the liver].
Topics: Catheterization; Catheters, Indwelling; Combined Modality Therapy; Doxorubicin; Epirubicin; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Mitomycin; Prognosis; Stomach Neoplasms; Survival Rate | 1992 |
[Nutritional support for cancer bearing patients].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Fluorouracil; Home Nursing; Humans; Infusion Pumps, Implantable; Liver Neoplasms; Male; Middle Aged; Mitomycin; Neoplasms; Parenteral Nutrition, Home; Quality of Life; Stomach Neoplasms | 1991 |
[A pilot study of the combination of 5-FU and epirubicin for gastric cancer as an adjuvant chemotherapy].
Topics: Administration, Oral; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Fluorouracil; Humans; Injections, Intravenous; Leukemia P388; Male; Mice; Middle Aged; Mitomycin; Mitomycins; Pilot Projects; Postoperative Care; Stomach Neoplasms | 1991 |
Organ conservation in bladder cancer.
Topics: Administration, Intravesical; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Humans; Mitomycin; Neoplasm Invasiveness; Urinary Bladder Neoplasms | 1991 |
Open phase II with 5-fluorouracil, 4-epi-doxorubicin and mitomycin C (FEM) in advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Evaluation; Epirubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Stomach Neoplasms; Survival Rate | 1990 |
Radio-immunoassay detection of interferon-gamma in urine after intravesical Evans BCG therapy.
Topics: Administration, Intravesical; Antineoplastic Agents; BCG Vaccine; Carcinoma in Situ; Epirubicin; Humans; Interferon-gamma; Mitomycin; Mitomycins; Radioimmunoassay; Urinary Bladder Neoplasms | 1990 |
Phase II study of combination 4'-epidoxorubicin and mitomycin C in recurrent epithelial ovarian cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Epirubicin; Female; Humans; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Ovarian Neoplasms | 1989 |
Effect of combination of 5-fluorouracil, epirubicin and mitomycin C (FEM) on advanced gastric carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Stomach Neoplasms | 1989 |
[In vitro sensitivity testing of human kidney tumors to cytostatic drugs with a rapid in vitro test].
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Cisplatin; Colony-Forming Units Assay; Dose-Response Relationship, Drug; Doxorubicin; Epirubicin; Humans; Kidney Neoplasms; Mitomycin; Mitomycins; Tumor Stem Cell Assay; Vincristine | 1986 |
Intravesical chemotherapy: studies on the relationship between osmolality and cytotoxicity.
Topics: Antineoplastic Agents; Carcinoma, Transitional Cell; Cell Line; Cisplatin; Colony-Forming Units Assay; Doxorubicin; Epirubicin; Ethoglucid; Humans; In Vitro Techniques; Mitomycin; Mitomycins; Osmolar Concentration; Stereoisomerism; Thiotepa; Tumor Stem Cell Assay; Urinary Bladder Neoplasms | 1986 |
Intravesical chemotherapy. Studies on the relationship between pH and cytotoxicity.
Topics: Antineoplastic Agents; Carcinoma, Transitional Cell; Cell Line; Cisplatin; Doxorubicin; Epirubicin; Ethoglucid; Humans; Hydrogen-Ion Concentration; Mitomycin; Mitomycins; Thiotepa; Tumor Stem Cell Assay; Urinary Bladder Neoplasms | 1986 |
5-Fluorouracil, 4-epidoxorubicin, and mitomycin C (FEM) combination chemotherapy for advanced gastric carcinoma. A phase-II trial by the "chemotherapiegruppe gastrointestinaler tumoren (CGT)".
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Drug Evaluation; Epirubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis; Neoplasm Recurrence, Local; Stomach Neoplasms | 1987 |
Chemotherapy of hormone-resistant carcinoma of the prostate: 4-epi-rubicin weekly v.s. DMF monthly.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Epirubicin; Fluorouracil; Humans; Male; Mitomycin; Mitomycins; Prostatic Neoplasms | 1987 |
Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected cases.
Topics: Adolescent; Adult; Aged; Antigens, Neoplasm; Carcinoma, Hepatocellular; Catheterization, Peripheral; Cell Division; Cell Survival; Chemoembolization, Therapeutic; Doxorubicin; Epirubicin; Female; Hepatic Artery; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Mitomycin; Necrosis; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Staining and Labeling | 1994 |
Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer.
Topics: Adult; Aged; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; CD57 Antigens; Cell Differentiation; Chromogranin A; Chromogranins; Cisplatin; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Humans; Ifosfamide; Immunologic Factors; Interferons; Karnofsky Performance Status; Life Tables; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multivariate Analysis; Neoplasm Proteins; Neoplasm Staging; Phosphopyruvate Hydratase; Prognosis; Proportional Hazards Models; Remission Induction; Retrospective Studies; Survival Rate; Synaptophysin; Vindesine | 1993 |
Curative treatments of murine Colon26 solid tumors by immunochemotherapy with G-CSF and OK-432.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Colonic Neoplasms; Cyclophosphamide; Cytotoxicity, Immunologic; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Immunologic Factors; Macrophages; Mice; Mice, Inbred BALB C; Mitomycin; Neoplasm Proteins; Picibanil; Recombinant Proteins; Tumor Cells, Cultured | 1995 |
[Intra-arterial infusion chemotherapy for advanced liver metastases from lung cancer via implantable vascular access: report of six cases].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Mitomycin | 1995 |
[A case report of far advanced gastric cancer with multiple liver metastasis (H3) treated with transarterial intermittent chemotherapy and intradermal administration of low molecular lipopolysaccharide (LPSp) extracted from Pantoea agglomerans].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Enterobacteriaceae; Epirubicin; Fluorouracil; Humans; Immunologic Factors; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Injections, Subcutaneous; Lipopolysaccharides; Liver Neoplasms; Male; Mitomycin; Molecular Weight; Stomach Neoplasms | 1995 |
[Hepatic artery chemotherapy-embolization and biological response modifiers for late hepatic carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Combined Modality Therapy; Epirubicin; Female; Fluorouracil; Humans; Immunologic Factors; Interferon-gamma; Liver Neoplasms; Male; Middle Aged; Mitomycin; Survival Rate | 1995 |
[Hepatic arterial infusion chemotherapy and embolization in the treatment of hepatic carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Gelatin Sponge, Absorbable; Hepatic Artery; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Survival Rate | 1994 |
Transcatheter arterial chemoembolization therapy with epirubicin hydrochloride, mitomycin C-iohexol-Lipiodol emulsion (EMILE) for hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheterization, Peripheral; Emulsions; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Iodized Oil; Iohexol; Liver Neoplasms; Male; Middle Aged; Mitomycin; Retrospective Studies | 1995 |
[Home therapy approach in cancer patients-chemotherapy (case 2-3)--intra-arterial infusion cancer chemotherapy for hepatic metastasis of colorectal cancer--case report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Cisplatin; Colorectal Neoplasms; Epirubicin; Female; Fluorouracil; Home Infusion Therapy; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Mitomycin | 1994 |
[A case of liver metastasis from bile duct cancer effectively treated with hepatic artery infusion chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Middle Aged; Mitomycin | 1994 |
The effects of chemotherapy including cisplatin on vitamin D metabolism.
Topics: 24,25-Dihydroxyvitamin D 3; 25-Hydroxyvitamin D3 1-alpha-Hydroxylase; Adult; Antineoplastic Combined Chemotherapy Protocols; Calcifediol; Calcitriol; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Genital Neoplasms, Female; Humans; Kidney Diseases; Kidney Tubules, Proximal; Middle Aged; Mitochondria; Mitomycin; Parathyroid Hormone; Vitamin D | 1993 |
[The significance of intra-arterial infusion therapy for neoadjuvant chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Lymphatic Metastasis; Mitomycin; Prognosis | 1994 |
[Hypervascular liver metastases of gastric cancer completely responding to transcatheter oily chemoembolization using epirubicin hydrochloride, mitomycin C and lipiodol].
Topics: Adenocarcinoma; Aged; Chemoembolization, Therapeutic; Epirubicin; Female; Humans; Iodized Oil; Liver Neoplasms; Mitomycin; Stomach Neoplasms | 1994 |
Repeated arterial infusion chemotherapy for inoperable hepatocellular carcinoma using an implantable drug delivery system.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Mitomycin | 1994 |
Enzyme activities and level of SH groups in breast carcinomas.
Topics: Antibiotics, Antineoplastic; Biomarkers, Tumor; Breast Neoplasms; Cell Cycle; DNA, Neoplasm; Epirubicin; Female; Glycolysis; Humans; Mitomycin; Neoplasm Staging; Sulfhydryl Compounds | 1993 |
[A new approach to intra-arterial infusion chemotherapy for breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Epirubicin; Female; Humans; Infusion Pumps; Infusions, Intra-Arterial; Middle Aged; Mitomycin; Thoracic Arteries | 1993 |
[Advanced breast cancer with onset of multi-organ metastases successfully treated with combined loco-regional therapies: a case report].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cholestasis; Combined Modality Therapy; Drainage; Epirubicin; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Mastectomy; Middle Aged; Mitomycin; Pleural Effusion, Malignant | 1993 |
[Prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization (TAE)--significance of repetitive therapies and responses to them within 6 months after the first intervention].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Epirubicin; Female; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Mitomycin; Prognosis; Regression Analysis; Retrospective Studies; Survival Rate; Time Factors | 1993 |
[Transcatheter hepatic segmental chemo-Lipiodol-embolization against hepatocellular carcinoma accompanied by tumor thrombosis in the portal vein].
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Mitomycin; Portal Vein; Thrombosis | 1993 |
[A case of gastric cancer with multiple liver metastases responding significantly to intra-arterial infusion of epirubicin/mitomycin C-lipiodol suspension].
Topics: Adenocarcinoma, Papillary; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cholecystectomy; Delayed-Action Preparations; Epirubicin; Gastrectomy; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Lymph Node Excision; Male; Middle Aged; Mitomycin; Stomach Neoplasms | 1993 |
Non-P-glycoprotein-mediated atypical multidrug resistance in a human bladder cancer cell line.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Carcinoma, Transitional Cell; Cisplatin; DNA Topoisomerases, Type II; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Fluorouracil; Humans; Mitomycin; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Selection, Genetic; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Verapamil; Vinca Alkaloids | 1995 |
Evaluation of antitumor activities of hyaluronate binding antitumor drugs: synthesis, characterization and antitumor activity.
Topics: Animals; Antibiotics, Antineoplastic; Drug Combinations; Drug Screening Assays, Antitumor; Epirubicin; Hyaluronan Receptors; Hyaluronic Acid; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mitomycin; Rats; Rats, Sprague-Dawley; Tissue Distribution; Tumor Cells, Cultured | 1996 |
In vitro synergistic effects of some novel Cu(II) complexes in combination with epirubicin and mitomycin C against HeLa-S3 cervical cancer cell line.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Division; Cisplatin; Copper; Cyclophosphamide; Drug Synergism; Epirubicin; Fluorouracil; HeLa Cells; Humans; Mitomycin; Organometallic Compounds; Vincristine | 1996 |
[Effects of anticancer drugs on vascular wall: histological and pharmacological studies].
Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Aorta; Blood Vessels; Endothelium, Vascular; Epirubicin; Fluorouracil; Mitomycin; Rabbits; Rats; Rats, Wistar | 1996 |
[The efficacy of ATP sensitivity assay on intravesical prophylactic instillation for superficial bladder cancer].
Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents; Doxorubicin; Drug Screening Assays, Antitumor; Epirubicin; Female; Humans; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms | 1996 |
Arteritis following intra-arterial chemotherapy for liver tumors.
Topics: Aged; Antibiotics, Antineoplastic; Arteritis; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Gelatin Sponge, Absorbable; Hepatic Artery; Humans; Injections, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Mitomycin; Radiography | 1997 |
Regional adjuvant chemotherapy after partial hepatectomy for metastatic colorectal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Catheters, Indwelling; Chemotherapy, Adjuvant; Colorectal Neoplasms; Doxorubicin; Epirubicin; Female; Fluorouracil; Hepatectomy; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Prognosis; Survival Rate | 1997 |
[Bone metastases responsive to pamidronate therapy in breast cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Doxorubicin; Epirubicin; Female; Humans; Infusions, Intravenous; Mitomycin; Pamidronate | 1997 |
[Combined intra-arterial locoregional and systemic treatment of nonresectable hepatic metastases of colorectal carcinoma].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Male; Middle Aged; Mitomycin; Time Factors | 1997 |
[Neoadjuvant intra-arterial chemotherapy based on chemosensitivity tests for locally invasive bladder cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Drug Administration Schedule; Drug Screening Assays, Antitumor; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Mitomycin; Peplomycin; Prognosis; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Vinblastine | 1997 |
Induction intraarterial chemotherapy for T4 breast cancer through an implantable port-catheter system.
Topics: Adult; Aged; Ambulatory Care; Angiography, Digital Subtraction; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brachial Artery; Breast Neoplasms; Carcinoma; Catheterization, Peripheral; Catheters, Indwelling; Coloring Agents; Epirubicin; Feasibility Studies; Female; Humans; Injections, Intra-Arterial; Mammary Arteries; Mammography; Middle Aged; Mitomycin; Neoplasm Staging; Remission Induction; Subclavian Artery; Treatment Outcome; Ultrasonography, Mammary | 1997 |
[Percutaneous transcatheter thermotherapy (PTCT): use of hotwire for local tumor control].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheterization; Combined Modality Therapy; Epirubicin; Female; Humans; Hyperthermia, Induced; Liver Neoplasms; Male; Middle Aged; Mitomycin; Rectal Neoplasms; Stomach Neoplasms | 1997 |
[Hepatic arterial chemotherapy for liver cancer over a period of 8 years].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Neoplasms; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Stomach Neoplasms; Survival Rate | 1997 |
[Evaluation of hepatic resection and hepatic arterial infusion chemotherapy for multiple liver metastases from colon cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Epirubicin; Female; Fluorouracil; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Survival Rate | 1997 |
[Liver metastases from breast cancer 14 years after radical mastectomy; successful treatment with hepatic arterial infusion chemotherapy and systemic endocrine therapy--a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Epirubicin; Fadrozole; Female; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Lymphatic Metastasis; Mastectomy, Radical; Medroxyprogesterone; Mitomycin; Time Factors | 1997 |
[Chemosensitivity test for human osteosarcoma cells].
Topics: Antibiotics, Antineoplastic; Bone Neoplasms; Drug Screening Assays, Antitumor; Epirubicin; Humans; Mitomycin; Osteosarcoma; Tumor Cells, Cultured | 1996 |
Effects of catechols on free radical formation by chemotherapeutic agents (adriamycin, farmorubicin, and mitomycin).
Topics: Antibiotics, Antineoplastic; Catecholamines; Deoxyribose; Doxorubicin; Epirubicin; Humans; Hydroxyl Radical; Mitomycin; Oxidants | 1997 |
Bladder cancer recurrence by implantation of exfoliated cells: is gamma-linolenic acid an effective tumoricidal agent?
Topics: Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Cell Adhesion; Drug Resistance, Neoplasm; Epirubicin; gamma-Linolenic Acid; Humans; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Seeding; Serum Albumin; Tumor Cells, Cultured; Tumor Stem Cell Assay; Urinary Bladder Neoplasms; Water | 1998 |
[Transcatheter oily chemoembolization and intermittent hepatic artery infusion chemotherapy in the management of advanced hepatocellular carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Drug Administration Schedule; Epirubicin; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Mitomycin | 1998 |
[Intra-arterial infusion chemotherapy for advanced endometrial cancer before surgical treatment].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Endometrial Neoplasms; Epirubicin; Female; Humans; Hysterectomy; Infusions, Intra-Arterial; Lymph Node Excision; Middle Aged; Mitomycin; Preoperative Care | 1998 |
[Appearance of extrahepatic lesions in the superior lip and orbit of a patient with liver metastases of gastric cancer following partial response by hepatic arterial infusion chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Epirubicin; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Lip Neoplasms; Liver Neoplasms; Male; Mitomycin; Orbital Neoplasms; Stomach Neoplasms | 1998 |
[Preoperative intra-arterial and venous neoadjuvant chemotherapy for advanced gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Epirubicin; Female; Fluorouracil; Gastrectomy; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Leucovorin; Lymph Node Excision; Male; Middle Aged; Mitomycin; Preoperative Care; Stomach Neoplasms | 1998 |
Nausea and vomiting induced by arterial chemo-embolization in patients with hepatocellular carcinoma and the antiemetic effect of ondansetron hydrochloride.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antiemetics; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Eating; Epirubicin; Female; Follow-Up Studies; Humans; Incidence; Infusions, Intra-Arterial; Injections, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Maleic Anhydrides; Middle Aged; Mitomycin; Nausea; Ondansetron; Polystyrenes; Quality of Life; Vomiting; Zinostatin | 1999 |
Anticancer drugs inhibit induction of NO synthase in rat in vivo.
Topics: Animals; Antibiotics, Antineoplastic; Enzyme Induction; Epirubicin; Lipopolysaccharides; Male; Mitomycin; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; Tissue Distribution | 1999 |
Perivesical fat necrosis after adjuvant intravesical chemotherapy.
Topics: Administration, Intravesical; Aged; Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cystectomy; Epirubicin; Fat Necrosis; Female; Humans; Male; Middle Aged; Mitomycin; Urinary Bladder Neoplasms | 1999 |
Efficacy of an implanted drug delivery system for advanced hepatocellular carcinoma using 5-fluorouracil, epirubicin and mitomycin C.
Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Survival Rate | 1999 |
The effects of two different cisplatin-based chemotherapy regimens on advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Lung Neoplasms; Male; Middle Aged; Mitomycin; Retrospective Studies; Survival Rate | 1999 |
[Percutaneous ethanol injection therapy with hepatic arterial infusion chemotherapy for liver metastases from gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Ethanol; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Injections, Intralesional; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Mitomycin; Stomach Neoplasms; Survival Rate | 1999 |
[Intraarterial chemotherapy for uterine cervical adenocarcinoma: evaluation of its efficacy as neoadjuvant therapy].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Magnetic Resonance Imaging; Middle Aged; Mitomycin; Neoadjuvant Therapy; Treatment Outcome; Uterine Cervical Neoplasms | 1999 |
[A case of recurrent pancreatic cancer brought into a complete response by a multimodal treatment with intraarterial chemotherapy and radiotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Mitomycin; Pancreatic Neoplasms; Remission Induction | 2000 |
Theoretical considerations and in vitro concentration response studies with two human colorectal carcinoma cell lines. The rational experimental base for clinical studies in regional chemotherapy.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Carcinoma; Cisplatin; Colorectal Neoplasms; Doxorubicin; Epirubicin; Floxuridine; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Melphalan; Mitomycin; Mitoxantrone; Tumor Cells, Cultured | 2000 |
Response of glassy-cell carcinoma of the cervix to cisplatin, epirubicin, and mitomycin C.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Cisplatin; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Magnetic Resonance Imaging; Mitomycin; Uterine Cervical Neoplasms | 2000 |
[Hepatic arterial infusion chemotherapy using totally implantable port system].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin | 2000 |
[Transcatheter arterial chemo-embolization using degradable starch microspheres (DSM) markedly effective for post-hepatectomy intra-hepatic recurrence in a patient with cholangioma].
Topics: Aged; Antibiotics, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cholangiocarcinoma; Epirubicin; Hepatectomy; Humans; Liver Neoplasms; Male; Microspheres; Mitomycin; Neoplasm Recurrence, Local; Postoperative Period; Starch | 2000 |
[Repetitive chemo-embolization with degradable starch microspheres (DSM) to each left and replaced right hepatic artery in a patient with multiple liver metastases of colon cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Colonic Neoplasms; Epirubicin; Fluorouracil; Hepatic Artery; Humans; Liver Neoplasms; Male; Mesenteric Artery, Superior; Microspheres; Middle Aged; Mitomycin; Starch | 2000 |
[Long-term survival of a patient with postoperative liver metastasis of stage IVa gallbladder cancer responding to hepatic arterial infusion chemotherapy].
Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Duodenal Neoplasms; Epirubicin; Fluorouracil; Gallbladder Neoplasms; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin | 2001 |
Malignant fibrous histiocytoma of the trunk metastatic to the liver: treatment with transcatheter intrahepatic chemoembolization.
Topics: Carboplatin; Chemoembolization, Therapeutic; Epirubicin; Histiocytoma, Benign Fibrous; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Mitomycin; Thoracic Neoplasms | 2001 |
Re: methods to improve efficacy of intravesical mitomycin C: results of a randomized phase III trial.
Topics: Administration, Intravesical; Antineoplastic Agents; Black or African American; Carcinoma, Transitional Cell; Clinical Trials, Phase III as Topic; Drug Resistance; Epirubicin; Humans; Hydrogen-Ion Concentration; Mitomycin; Multicenter Studies as Topic; Osmolar Concentration; Randomized Controlled Trials as Topic; Urinary Bladder Neoplasms | 2001 |
[Clinical effectiveness of intra-arterial chemotherapy combined with degradable starch microspheres (DSM) for liver metastases and prediction of effectiveness by diagnostic imaging].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Colorectal Neoplasms; Epirubicin; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin; Starch; Stomach Neoplasms; Tomography, X-Ray Computed | 2001 |
Frequency of positive biopsies after visual disappearance of superficial bladder cancer marker lesions.
Topics: Administration, Intravesical; Antibiotics, Antineoplastic; BCG Vaccine; Biopsy; Carcinoma, Transitional Cell; Clinical Protocols; Clinical Trials, Phase II as Topic; Cystoscopy; Epirubicin; Humans; Mitomycin; Neoplasm Recurrence, Local; Neoplasm, Residual; Urinary Bladder Neoplasms | 2001 |
Docetaxel induced durable response in advanced extramammary Paget's disease: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Administration Schedule; Epirubicin; Fluorouracil; Humans; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Paclitaxel; Paget Disease, Extramammary; Radiography; Scrotum; Skin Neoplasms; Taxoids; Vincristine | 2002 |
Preoperative transcatheter arterial infusion chemotherapy for locally advanced breast cancer (stage IIIb) for down-staging and increase of resectability.
Topics: Adult; Aged; Antineoplastic Agents; Breast; Breast Neoplasms; Combined Modality Therapy; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Middle Aged; Mitomycin; Neoplasm Staging; Preoperative Care; Survival Rate | 2002 |
Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Mitomycin; Neoplasm Staging; Preoperative Care; Prognosis; Salvage Therapy; Stomach Neoplasms; Survival Analysis | 2002 |
[Evaluation of intra-arterial infusion chemotherapy for liver metastasis from gastric cancer FEM--combination therapy of 5 FU, Epirubicin and MMC].
Topics: Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Fluorouracil; Hepatectomy; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin; Stomach Neoplasms; Survival Rate | 2002 |
[A case report of hepatocellular carcinoma with portal thrombus responding to hepatic arterial infusion chemo-lipiodolization].
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Humans; Iodized Oil; Liver Neoplasms; Male; Mitomycin; Neoplasm Recurrence, Local; Portal Vein; Thrombosis | 2002 |
[Clinical efficacy of the combination chemotherapy of high-dose epirubicin in non-small cell lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin | 2001 |
[Early effect of intra-arterial chemotherapy combined with degradable starch microspheres for malignant hepatic tumors].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Doxorubicin; Epirubicin; Female; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver; Liver Neoplasms; Male; Middle Aged; Mitomycin; Starch; Tomography, X-Ray Computed | 2003 |
[Apoptosis of human pancreatic carcinoma cell lines induced by combinations of chemotherapeutic drugs].
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carboplatin; Doxorubicin; Epirubicin; Fluorouracil; Humans; Mitomycin; Pancreatic Neoplasms; Tumor Cells, Cultured | 1999 |
Clinical benefit of chemosensitivity test for patients with regional lymph node-positive esophageal squamous cell carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Drug Screening Assays, Antitumor; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Survival Analysis | 2003 |
[Evaluation of intraarterial infusion chemotherapy for liver metastasis from gastric cancer FEM: combination therapy of 5-FU, epirubicin and MMC].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Gastrectomy; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Stomach Neoplasms; Survival Rate | 2003 |
[Validity of two-hour continuous hepatic arterial infusion chemotherapy with low-dose 5-FU for unresectable liver metastasis from colorectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Epirubicin; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Middle Aged; Mitomycin; Prognosis; Reproducibility of Results; Survival Rate | 2003 |
Chemotherapy in the treatment of advanced gallbladder cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Doxorubicin; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Gallbladder Neoplasms; Humans; Male; Middle Aged; Mitomycin; Odds Ratio; Retrospective Studies; Survival Analysis; Treatment Outcome | 2004 |
Radiotherapy combined with transarterial infusion chemotherapy and concurrent infusion of a vasoconstrictor agent for nonresectable advanced hepatic hilar duct carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Combined Modality Therapy; Epinephrine; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Liver; Male; Middle Aged; Mitomycin; Prognosis; Radiotherapy, Conformal; Survival Rate; Treatment Outcome; Vasoconstrictor Agents | 2004 |
A pilot study of neoadjuvant chemotherapy with mitomycin C, etoposide, cisplatin, and epirubicin for adenocarcinoma of the cervix.
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Chemotherapy, Adjuvant; Cisplatin; Dose-Response Relationship, Drug; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Hysterectomy; Lymphatic Metastasis; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Radiotherapy, Adjuvant; Statistics as Topic; Treatment Outcome; Uterine Cervical Neoplasms; Women's Health | 2004 |
[Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Epirubicin; Ethanol; Female; Follow-Up Studies; Humans; Injections, Subcutaneous; Liver Neoplasms; Male; Mitomycin; Retrospective Studies; Survival Rate | 2004 |
Transcatheter arterial chemoembolization for hepatocellular carcinoma fed by the reconstructed inferior phrenic artery: anatomical and technical analysis.
Topics: Adrenal Glands; Aged; Antibiotics, Antineoplastic; Arteries; Carcinoma, Hepatocellular; Catheters, Indwelling; Celiac Artery; Chemoembolization, Therapeutic; Collateral Circulation; Epirubicin; Female; Humans; Liver Neoplasms; Male; Mesenteric Artery, Superior; Middle Aged; Mitomycin; Pancreas; Retrospective Studies; Stomach; Treatment Outcome | 2004 |
Primary sweat gland carcinosarcoma of the scrotal skin.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinosarcoma; Chemotherapy, Adjuvant; Cisplatin; Epirubicin; Fatal Outcome; Fluorouracil; Humans; Male; Mitomycin; S100 Proteins; Scrotum; Skin Neoplasms; Sweat Gland Neoplasms; Vincristine | 2004 |
[Hepatic arterial infusion and occlusion technique for the evaluation of the hepatic resection to control the local liver tumor].
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Epirubicin; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Microspheres; Middle Aged; Mitomycin; Starch; Stomach Neoplasms | 2004 |
[A case of diffuse type of hepatocellular carcinoma with tumor thrombosis of inferior vena cava (Vv3) and main trunk of portal vein (Vp4), showing marked response to transcatheter arterial chemoembolization with degradable starch microspheres (DSM-TACE)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Drug Administration Schedule; Epirubicin; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Neoplastic Cells, Circulating; Portal Vein; Starch; Vena Cava, Inferior | 2004 |
[Efficacy of hepatic arterial infusion therapy for advanced hepatocellular carcinoma using 5-fluorouracil, epirubicin and mitomycin-C].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Epirubicin; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Survival Rate | 2005 |
Effect of hyperthermia on the cytotoxicity of 4 chemotherapeutic agents currently used for the treatment of transitional cell carcinoma of the bladder: an in vitro study.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coloring Agents; Combined Modality Therapy; Deoxycytidine; Epirubicin; Gemcitabine; Humans; Hyperthermia, Induced; Indolequinones; Mitomycin; Tetrazolium Salts; Thiazoles; Urinary Bladder Neoplasms | 2005 |
Mitomycin C and epirubicin: functional bladder damage in rats after repeat intravesical instillations.
Topics: Administration, Intravesical; Animals; Antibiotics, Antineoplastic; Epirubicin; Female; Mitomycin; Rats; Rats, Wistar; Urinary Bladder; Urodynamics; Weight Gain | 2005 |
[A case of hepatocellular carcinoma with tumor thrombi in the first branch of the portal vein and hepatic vein trunks treated by transcatheter hepatic arterial chemoembolization and hepatic arterial infusion chemotherapy--two years and six months follow-u
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Drug Administration Schedule; Epirubicin; Fluorouracil; Follow-Up Studies; Hepatic Artery; Hepatic Veins; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Mitomycin; Neoplastic Cells, Circulating; Portal Vein; Thrombosis | 2005 |
Increased dosage of epirubicin and mitomycin-C for the treatment of metastatic adenocarcinoma of unknown primary site.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Biopsy; Dose-Response Relationship, Drug; Epirubicin; Humans; Leukopenia; Male; Mitomycin; Neoplasm Metastasis; Neoplasms, Unknown Primary; Neutropenia; Treatment Outcome | 1989 |
Second and third line chemotherapy in advanced breast cancer.
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Epirubicin; Female; Humans; Mitomycin; Neoplasm Metastasis; Neoplasm Staging; Vinblastine; Vincristine | 1989 |
Transcatheter arterial chemoembolization in patients with hepatocellular carcinoma and coexisting hepatic cavernous hemangioma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheterization, Peripheral; Chemoembolization, Therapeutic; Contrast Media; Epirubicin; Female; Follow-Up Studies; Hemangioma, Cavernous; Humans; Iodized Oil; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mitomycin; Neoplasms, Multiple Primary; Retreatment; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
[Investigation of bile duct injury after transcatheter arterial chemoembolization].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bile Ducts; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cholangiography; Cisplatin; Dilatation, Pathologic; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Iodized Oil; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mitomycin; Ultrasonography | 2005 |
Conservative treatment of high grade superficial bladder tumours.
Topics: Adjuvants, Immunologic; Administration, Intravesical; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Carcinoma, Transitional Cell; Epirubicin; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Urinary Bladder Neoplasms | 2005 |
[A case of postoperative liver metastasis from bile duct carcinoma responding to transarterial chemoembolization].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Chemoembolization, Therapeutic; Drug Administration Schedule; Epirubicin; Fluorouracil; Hepatic Artery; Humans; Liver Neoplasms; Male; Microspheres; Mitomycin; Polymers; Postoperative Period; Remission Induction | 2006 |
Meglumine Eicosapentaenoic acid (MeEPA) a new soluble omega-3 fatty acid formulation: in vitro bladder cancer cytotoxicity tests in combination with epirubicin and mitomycin.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Drug Combinations; Drug Screening Assays, Antitumor; Drug Synergism; Eicosapentaenoic Acid; Epirubicin; Fatty Acids, Omega-3; Humans; Meglumine; Mitomycin; Urinary Bladder Neoplasms | 2006 |
[Adriamycin and mitomycin dose-dependently downregulate X-kinked inhibitor of apoptosis protein in human bladder cancer cells].
Topics: Antibiotics, Antineoplastic; Apoptosis; Cell Line, Tumor; Dose-Response Relationship, Drug; Epirubicin; Humans; Mitomycin; Urinary Bladder Neoplasms; X-Linked Inhibitor of Apoptosis Protein | 2006 |
A chemosensitivity test for superficial bladder cancer based on three-dimensional culture of tumour spheroids.
Topics: Antineoplastic Agents; Ciprofloxacin; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Epirubicin; Humans; Mitomycin; Spheroids, Cellular; Thiotepa; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Verapamil | 2007 |
[Prolonged hypoxia induces GST-pi expression and drug resistance in lung adenocarcinoma cell line SPCA1].
Topics: Adenocarcinoma; Cell Hypoxia; Cell Line, Tumor; Drug Resistance, Neoplasm; Epirubicin; Glutathione S-Transferase pi; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Mitomycin; Plasmids; Transfection | 2007 |
[New therapeutics in the suppression of superficial bladder carcinoma].
Topics: Adjuvants, Immunologic; Administration, Intravesical; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Carcinoma, Papillary; Deoxycytidine; Epirubicin; Gemcitabine; Humans; Mitomycin; Treatment Outcome; Urinary Bladder Neoplasms | 2006 |
[A case of unresectable advanced gallbladder cancer treated by systemic chemotherapy combined with hepatic arterial infusion].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Epirubicin; Female; Gallbladder Neoplasms; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Middle Aged; Mitomycin; Oxonic Acid; Remission Induction; Tegafur | 2007 |
Multidrug resistance in a urothelial cancer cell line after 3, 1-hour exposures to mitomycin C.
Topics: Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Epirubicin; Follow-Up Studies; Humans; Intracellular Fluid; Mitomycin; Phenotype; Spheroids, Cellular; Time Factors; Urinary Bladder Neoplasms | 2007 |
Platinum-based chemotherapy in triple-negative breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Vinblastine | 2008 |
Pilot study of combination therapy with transcatheter arterial infusion chemotherapy using iodized oil and percutaneous radiofrequency ablation during occlusion of hepatic blood flow for hepatocellular carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Balloon Occlusion; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Combined Modality Therapy; Epirubicin; Female; Follow-Up Studies; Hepatic Artery; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Mitomycin; Pilot Projects; Prospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
[Analysis of severe complications after transcatheter arterial chemoembolization for primary hepatocellular carcinoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Fluorouracil; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Iodized Oil; Liver Failure; Liver Neoplasms; Male; Middle Aged; Mitomycin; Pulmonary Embolism; Young Adult | 2008 |
Drug eruption due to intravesical instillations of both epirubicin and mitomycin C.
Topics: Administration, Intravesical; Antibiotics, Antineoplastic; Drug Eruptions; Epirubicin; Humans; Male; Middle Aged; Mitomycin; Urinary Bladder Neoplasms | 2009 |
[Water mobility of diffusion MRI in prediction of response to chemoembolization in liver cancer].
Topics: Adult; Aged; Chemoembolization, Therapeutic; Cisplatin; Colonic Neoplasms; Diffusion Magnetic Resonance Imaging; Epirubicin; Female; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Mitomycin; Predictive Value of Tests; Sensitivity and Specificity; Stomach Neoplasms; Treatment Outcome | 2009 |
Multidrug resistance in a urothelial cancer cell line after 1-hour mitomycin C exposure.
Topics: Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Cell Line, Tumor; Drug Resistance, Neoplasm; Epirubicin; Humans; Mitomycin; Time Factors; Urinary Bladder Neoplasms | 2009 |
Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy?
Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Combined Modality Therapy; Epirubicin; Female; Follow-Up Studies; Humans; Kidney Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Nephrectomy; Postoperative Care; Retrospective Studies; Time Factors; Ureter; Ureteral Neoplasms; Young Adult | 2010 |
Editorial comment.
Topics: Administration, Intravesical; Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Combined Modality Therapy; Epirubicin; Humans; Kidney Neoplasms; Mitomycin; Neoplasm Recurrence, Local; Nephrectomy; Postoperative Care; Ureter; Ureteral Neoplasms | 2010 |
[A case in which intra-arterial chemotherapy for simultaneous hepatic metastases markedly improved AFP-producing gastric cancer].
Topics: Adenocarcinoma; Aged; alpha-Fetoproteins; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Female; Fluorouracil; Gastrectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin; Stomach Neoplasms | 2009 |
Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chi-Square Distribution; Cisplatin; Combined Modality Therapy; Diagnostic Imaging; Doxorubicin; Epirubicin; Female; Humans; Iodized Oil; Liver Neoplasms; Logistic Models; Male; Middle Aged; Mitomycin; Neoplasm Invasiveness; Neoplasm Staging; Proportional Hazards Models; Prospective Studies; Surveys and Questionnaires; Survival Rate; Treatment Outcome; Zinostatin | 2010 |
[Evaluation of transhepatic artery chemotherapy for highly advanced hepatocellular carcinoma].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Mitomycin; Treatment Outcome | 2010 |
[Evaluation of the efficacy of bronchial arterial infusion chemotherapy for the treatment of central non-small cell lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Arteries; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Epirubicin; Female; Follow-Up Studies; Humans; Infusions, Intra-Arterial; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Survival Rate | 2011 |
Adjuvant chemolipiodolization reduces early recurrence derived from intrahepatic metastasis of hepatocellular carcinoma after hepatectomy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Case-Control Studies; Chemoembolization, Therapeutic; Chemotherapy, Adjuvant; Combined Modality Therapy; Epirubicin; Ethiodized Oil; Female; Follow-Up Studies; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Retrospective Studies | 2011 |
Risk factors for the leakage of chemotherapeutic agents into systemic circulation after transcatheter arterial chemoembolization of hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Catheterization; Chemoembolization, Therapeutic; Epirubicin; Ethiodized Oil; Female; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Grading; Prospective Studies; Risk Factors; Taiwan | 2011 |
BRCA1 and GATA3 corepress FOXC1 to inhibit the pathogenesis of basal-like breast cancers.
Topics: Antineoplastic Agents; Base Sequence; BRCA1 Protein; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Drug Resistance, Neoplasm; Epirubicin; Epithelial-Mesenchymal Transition; Female; Fluorouracil; Forkhead Transcription Factors; GATA3 Transcription Factor; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Inhibitory Concentration 50; Mitomycin; Molecular Sequence Data; Neoplasms, Basal Cell; Phenotype; Promoter Regions, Genetic; Protein Binding; RNA Interference; Transcription, Genetic | 2012 |
Comparison of local control effects of superselective transcatheter arterial chemoembolization using epirubicin plus mitomycin C and miriplatin for hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chi-Square Distribution; Epirubicin; Female; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Organoplatinum Compounds; Statistics, Nonparametric; Treatment Outcome | 2012 |
Prognostic significance of intraoperative chemotherapy and extensive lymphadenectomy in patients with node-negative gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Gastrectomy; Humans; Intraoperative Period; Leucovorin; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Rate | 2012 |
Transcatheter arterial infusion chemotherapy prior to radiofrequency thermal ablation for single hepatocellular carcinoma reduces the risk of intrahepatic distant recurrence.
Topics: Aged; Carcinoma, Hepatocellular; Catheter Ablation; Chemotherapy, Adjuvant; Epirubicin; Ethiodized Oil; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Mitomycin; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome | 2012 |
Liver fibrosis and five year survival of hepatocellular cancer cases undergoing transcatheter arterial chemo embolization using small doses.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chi-Square Distribution; Collagen Type III; Collagen Type IV; Epirubicin; Female; Fluorouracil; Humans; Hyaluronic Acid; Iodized Oil; Kaplan-Meier Estimate; Laminin; Liver Cirrhosis; Liver Neoplasms; Male; Mitomycin; Transforming Growth Factor beta1; Treatment Outcome | 2012 |
Dual-phase CT angiography through the port-catheter system for hepatic arterial infusion chemotherapy using multislice CT: assessment of system dysfunction and impact on predicting clinical problems.
Topics: Aged; Aged, 80 and over; Angiography, Digital Subtraction; Antineoplastic Agents; Carcinoma, Hepatocellular; Cisplatin; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Predictive Value of Tests; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Vascular Access Devices; Vascular Patency | 2012 |
Effect of transcatheter arterial chemoembolization prior to surgical resection for hepatocellular carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Case-Control Studies; Chemoembolization, Therapeutic; Epirubicin; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Mitomycin; Neoplasm Staging; Prognosis; Survival Rate | 2013 |
The investigation of a traditional Chinese medicine, Guizhi Fuling Wan (GFW) as an intravesical therapeutic agent for urothelial carcinoma of the bladder.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Checkpoint Kinase 2; Cisplatin; Cyclin-Dependent Kinase Inhibitor p21; Drugs, Chinese Herbal; Epirubicin; Humans; Mitomycin; Phytotherapy; Protein Serine-Threonine Kinases; Sincalide; Urinary Bladder; Urinary Bladder Neoplasms; Urothelium | 2013 |
Hepatocellular carcinoma associated with Budd-Chiari syndrome: imaging features and transcatheter arterial chemoembolization.
Topics: Adult; alpha-Fetoproteins; Angiography; Angioplasty; Antineoplastic Combined Chemotherapy Protocols; Budd-Chiari Syndrome; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Ethiodized Oil; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mitomycin; Organoplatinum Compounds; Oxaliplatin; Retrospective Studies; Stents; Tomography, X-Ray Computed | 2013 |
The effect of photochemical internalization of bleomycin in the treatment of urothelial carcinoma of the bladder: an in vitro study.
Topics: Animals; Antibiotics, Antineoplastic; Bleomycin; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxycytidine; Dose-Response Relationship, Drug; Drug Synergism; Epirubicin; Gemcitabine; Humans; Light; Mitomycin; Photochemotherapy; Photosensitizing Agents; Porphyrins; Rats; Time Factors; Urinary Bladder Neoplasms | 2014 |
Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinoma.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Ethiodized Oil; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Mitomycin; Retrospective Studies; Treatment Outcome | 2014 |
Combination chemotherapy for metastatic extramammary Paget disease.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Bone Neoplasms; Carboplatin; Combined Modality Therapy; Epirubicin; Female; Fluorouracil; Genital Neoplasms, Male; Humans; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Paget Disease, Extramammary; Retrospective Studies; Treatment Outcome; Vincristine; Vulvar Neoplasms | 2014 |
Combined chemohyperthermia: 10-year single center experience in 160 patients with nonmuscle invasive bladder cancer.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Female; Humans; Hyperthermia, Induced; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Prospective Studies; Time Factors; Urinary Bladder Neoplasms | 2014 |
Metronomic adjuvant chemotherapy improves treatment outcome in nasopharyngeal carcinoma patients with postradiation persistently detectable plasma Epstein-Barr virus deoxyribonucleic acid.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Chemotherapy, Adjuvant; Cisplatin; DNA, Viral; Drug Combinations; Epirubicin; Female; Fluorouracil; Herpesvirus 4, Human; Humans; Induction Chemotherapy; Leucovorin; Male; Middle Aged; Mitomycin; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Radiotherapy, Conformal; Retrospective Studies; Tegafur; Treatment Outcome; Uracil | 2014 |
High-dose chemotherapeutics of intravesical chemotherapy rapidly induce mitochondrial dysfunction in bladder cancer-derived spheroids.
Topics: Administration, Intravesical; Animals; Antineoplastic Agents; DNA Fragmentation; Epirubicin; Humans; Male; Membrane Potential, Mitochondrial; Mice, Inbred NOD; Mice, SCID; Mitochondria; Mitomycin; Neoplasm Transplantation; Spheroids, Cellular; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2015 |
XRCC1 polymorphisms associated with survival among Chinese bladder cancer patients receiving epirubicin and mitomycin C.
Topics: Aged; Alleles; Biomarkers, Pharmacological; China; Disease-Free Survival; DNA-Binding Proteins; Epirubicin; Female; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Mitomycin; Polymorphism, Single Nucleotide; Urinary Bladder Neoplasms; X-ray Repair Cross Complementing Protein 1 | 2015 |
Ablative Intravesical Chemotherapy for Small Recurrent Non-Muscle-Invasive Bladder Cancer: A Prospective Study.
Topics: Administration, Intravesical; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents; Combined Modality Therapy; Cystoscopy; Disease-Free Survival; Epirubicin; Female; Humans; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Prospective Studies; Remission Induction; Treatment Outcome; Urinary Bladder Neoplasms | 2016 |
Hepatic arterial infusion chemotherapy using fluorouracil, epirubicin, and mitomycin C for patients with liver metastases from gastric cancer after treatment failure of systemic S-1 plus cisplatin.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Catheters, Indwelling; Cisplatin; Disease Progression; Drug Combinations; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Oxonic Acid; Stomach Neoplasms; Survival Rate; Tegafur; Tomography, X-Ray Computed; Treatment Failure; Treatment Outcome | 2016 |
GSTP1 and GSTO1 single nucleotide polymorphisms and the response of bladder cancer patients to intravesical chemotherapy.
Topics: Administration, Intravesical; Aged; Alleles; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; Genotype; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mitomycin; Neoplasm Grading; Polymorphism, Single Nucleotide; Retrospective Studies; Treatment Outcome; Tumor Burden; Urinary Bladder Neoplasms | 2015 |
Intravesical chemotherapy use after radical nephroureterectomy: A national survey of urologic oncologists.
Topics: Administration, Intravesical; Antineoplastic Agents; BCG Vaccine; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Doxorubicin; Epirubicin; Humans; Instillation, Drug; Kidney Neoplasms; Mitomycin; Neoplasm Recurrence, Local; Nephroureterectomy; Oncologists; Perioperative Care; Retrospective Studies; Surveys and Questionnaires; Thiotepa; Ureteral Neoplasms; Urinary Bladder Neoplasms | 2017 |
Toward Better Predictions of Chemosensitivity: Comparative Study of Conventional and Simulated Chemosensitivity Tests for Bladder Cancer Cell Lines.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Docetaxel; Epirubicin; Gemcitabine; Humans; Mitomycin; Urinary Bladder Neoplasms | 2017 |
Transcatheter Arterial Chemoembolization with Spherical Embolic Agent in Patients with Pulmonary or Mediastinal Metastases from Breast Cancer.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Chemoembolization, Therapeutic; Epirubicin; Female; Fluorouracil; Humans; Lung Neoplasms; Microspheres; Middle Aged; Mitomycin; Survival Rate; Treatment Outcome | 2017 |
Update on the role of endovesical chemotherapy in nonmuscle-invasive bladder cancer.
Topics: Administration, Intravesical; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Combined Modality Therapy; Doxorubicin; Epirubicin; Humans; Mitomycin; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Practice Guidelines as Topic; Urinary Bladder Neoplasms | 2018 |
Predictive factors for the benefit of triple-drug transarterial chemoembolization for patients with unresectable hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Clinical Trials, Phase III as Topic; Cyclobutanes; Emulsions; Epirubicin; Ethiodized Oil; Female; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Organoplatinum Compounds; Retrospective Studies; Survival Analysis; Treatment Outcome; Young Adult | 2019 |
Advanced extramammary Paget disease treated with neoadjuvant chemotherapy: A report of two cases.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Epirubicin; Fluorouracil; Groin; Humans; Lymph Node Excision; Male; Mitomycin; Neoadjuvant Therapy; Paget Disease, Extramammary; Skin Neoplasms; Vincristine | 2020 |
[Intravesical adjuvant regimen of epitubicin for intermediate risk NMIBC: Feasability study from CC-AFU vessie].
Topics: Adjuvants, Immunologic; Administration, Intravesical; Aged; Antibiotics, Antineoplastic; BCG Vaccine; Clinical Protocols; COVID-19 Drug Treatment; Epirubicin; Female; Humans; Male; Mitomycin; Neoplasm Invasiveness; Retrospective Studies; Urinary Bladder Neoplasms | 2022 |
[Guidelines from the cancer committee of the French Association of Urology (CC-AFU) for adequate intravesical instillations of Mitomycin C, Epirubicin, and BCG for non-muscle invasive bladder cancer].
Topics: Administration, Intravesical; Antibiotics, Antineoplastic; BCG Vaccine; Epirubicin; Female; Humans; Male; Mitomycin; Neoplasm Invasiveness; Urinary Bladder Neoplasms; Urology | 2022 |
Evaluation of thermal dose effect in radiofrequency-induced hyperthermia with intravesical chemotherapy for nonmuscle invasive bladder cancer.
Topics: Combined Modality Therapy; Epirubicin; Humans; Hyperthermia, Induced; Mitomycin; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms | 2023 |
Long-term prevention of bladder cancer progression by alpha1-oleate alone or in combination with chemotherapy.
Topics: Animals; Antibiotics, Antineoplastic; Epirubicin; Mice; Mitomycin; Neoplasm Recurrence, Local; Oleic Acid; Urinary Bladder; Urinary Bladder Neoplasms | 2023 |